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The intracellular protozoan parasite Toxoplasma gondii infects humans and other 
warm-blooded animals. Understanding the pathogenesis of infection and immunity to 
the parasite is important since this pathogen is capable of causing fatal disease in 
immunocompromised hosts. T. gondii infection elicits IL-12 release from innate 
immune cells, resulting in high level IFN-γ production. This confers resistance to 
infection through T cell dependent Type I immunity. Signal transduction pathways 
involved in IL-12 production, a little understood area, are the major focus of this 
dissertation.   
 
Neutrophils are innate immune cells capable of IL-12 production during T. gondii 
infection. I found that JNK2 MAPK is the major isoform expressed in mouse 
neutrophils. My results show that JNK2 plays a major role in PMN IL-12 and 
CCL/MCP-1 production during in vitro parasite stimulation. Neutrophil chemotaxis 
was also partially dependent upon JNK2, whereas oxidative burst and phagocytic 
activities were not affected by absence of this MAPK protein. 
 
I examined the role of JNK2 in response to T. gondii infection in vivo. I found that 
JNK2 plays a role in T. gondii-induced immunopathology since absence of JNK2 
contributed to enhanced disease resistance associated with alleviated pathology in the 
small intestine and decreased neutrophil recruitment at this site. Surprisingly, and in 
contrast to my in vitro data, JNK2 negatively regulated IL-12 production during in 
vivo infection. 
 
Toll-like receptor adaptor protein MyD88 is important for IL-12 induction during 
Toxoplasma infection. During oral T. gondii infection, I found that MyD88 was 
essential for controlling parasite burden leading to disease resistance. In addition, I 
found that neutrophil recruitment and expression of IGTP, a molecule required for 
control of infection, was also dependent upon MyD88 signaling. Interestingly, while 
IL-12 was greatly diminished in the absence of this molecule, T cell dependent IFN-γ 
responses were nevertheless generated. Importantly, I found that MyD88 was not 
required for development of protective immunity to T. gondii. Thus, while MyD88 
signaling was required for microbicidal control of infection, it was not necessary for 
initiation of adaptive immunity to this parasite.  
 
In summary, this dissertation elucidates the complex roles of JNK2 and MyD88 
signaling pathways in IL-12 production and resistance to Toxoplasma infection. 
Investigating the functions of these molecules in response to T. gondii contributes to a 
clearer understanding of the immunopathogenesis of infection with Toxoplasma and 
other microbial pathogens.   
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1. Life cycle of Toxoplasma gondii 
Toxoplasma gondii is an obligate intracellular protozoan parasite. It was initially 
found in tissues of a hamster-like african rodent, the gundi (Ctenodactylus gundi). 
Nicolle and Manceaux named this pathogen as a new organism in 1909 based on the 
morphology (toxo = arc or bow, plasma = life) and the host species in which the 
parasite was originally discovered (1). T. gondii is a coccidian belonging to phylum 
Apicomplexa that also includes the medically important Plasmodium spp. and 
Cryptosporidium parvum. T. gondii is the only species in genus Toxoplasma.  
 
The complete life cycle of T. gondii was elucidated in 1970 when members of the 
family Felidae, including the domestic cat, were identified as definitive hosts of the 
parasite (2) (Fig.1.1). Most warm-blooded animals, including humans, serve as 
intermediate hosts. Three different infective forms of Toxoplasma play roles in disease 
transmission: sporozoite-containing oocysts, tachyzoites and bradyzoite-containing 
cysts. Oocysts, 10 x 12 µm, are generated by gametogenesis inside the enterocytes of 
the felid. In this host,  there are five stages of asexual development (type A-E) of T. 
gondii within intestinal mucosa that occur before entering sexual stages to produce 
oocysts (3, 4). During acute infection, cats can shed millions of oocysts over a period 
of 7-21 days (5). They are shed in the feces into the environment and become 
sporulated as sporozoite-containing oocysts. Each oocyst contains 2 sporocysts with 4 
sporozoites per sporocyst. Sporulation occurs outside the host within 1-21 days 
depending upon environmental conditions. T. gondii oocysts are environmentally 
resistant. They can survive in seawater, soil, detergent, disinfectant, refrigeration and 
warm water. Studies have demonstrated that oocysts remain infective (tested by 
bioassay in mice) when the oocysts are stored at room temperature for up to 200 days 
(6-9).  
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Toxoplasma can be transmitted to intermediate hosts through fecal-oral contamination, 
animal-to-animal carnivorism, consumption of infected undercooked meat and 
transplacental transmission. Pigs and small ruminants commonly harbor the tissue 
cysts, whereas the parasite is present within cattle at very low prevalence (10). 
Because intermediate hosts can ingest oocyst-contaminated food or water 
inadvertently, this route of transmission contributes to widespread infection in 
herbivore animals and vegetarians, and this impacts public health concerns regarding 
foodborne and waterborne zoonosis (1, 8, 11-13).  
 
Upon ingestion of oocysts, sporozoites are liberated by enzymatic digestion inside the 
gastrointestinal tract giving rise to the haploid tachyzoite stage. The crescent-shaped 
tachyzoite, 2-4 µm wide and 4-8 µm long, is a rapidly dividing form of T. gondii 
associated with the acute infection. It invades virtually all nucleated cells and 
replicates inside a parasitophorous vacuole formed during invasion of host cells (14-
16). After tachyzoite egress, contiguous cells are infected and the parasite 
disseminates throughout the body. Lysis of host cell leads to tissue inflammation and  
necrosis. In response to immune pressure and intrinsic programming within the 
parasite, tachyzoites transform into latent bradyzoites and become encysted in the 
brain, heart, and muscle. In this manner, the parasite establishes life-long infection in 
its host (17, 18). Cysts usually cause no immune reaction and remain in the tissues 
until they are consumed by the feline or human. 
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Figure 1.1. Life cycle of Toxoplasma gondii. Cat and feline family members are 
definitive hosts. They become infected by predation and carnivorism of infected 
rodents harboring dormant bradyzoite-containing cyst in their brains and muscles (1). 
Gametogenesis occurs in the feline intestinal mucosa forming unsporulated oocysts 
which later are shed in feces (2). The oocysts become sporulated and infective in the 
environment (3). Toxoplasma can be transmitted to intermediate hosts by ingestion of 
sporulated oocysts within fecally contaminated food  (4), by ingestion of cyst-
containing undercooked meat (5), by transplacental infection (6) or by organ 
transplantation from infected individuals (7).  
Predation 
Consume  
undercooked 
meat 
Co
n
ge
n
ita
l 
tr
an
sm
is
si
o
n
 
Fecal-oral 
contamination 
Ingestion 
Sporulated oocyst 
Bradyzoite-containing cyst 
Tachyzoite 
R
ei
n
fe
ct
io
n
 
Ingestion 
O
rg
an
 
 
tr
an
sp
la
n
ta
tio
n
 
Unsporulated oocyst 
Organ 
recipient 
Fetus 
2 
3 
4 
1 
5 
6 7 
4 
 5 
2. Clinical and veterinary importance of T. gondii 
The disease caused by Toxoplasma infection is referred to as toxoplasmosis. The 
disease impact raises serious concerns in both medical and veterinary health as a major 
zoonotic infection. Toxoplasmosis is estimated to be the third leading cause of food- 
related deaths in the USA following salmonellosis and listeriosis (19). The 
seroprevalence of T. gondii  varies highly in human and animals throughout the world. 
Several factors could contribute to variable infection rates, including meat 
consumption behaviour, food production practices, and cat feces-related hygiene (20). 
In humans, the incidence of the infection is as high as 75% in El Salvador and nearly 
one quarter of adults and adolescents (22.5%) in USA are estimated to be infected (21). 
In the latter group,  persons infected with T. gondii were more likely to be infected 
with Toxocara (22). Cases of congenital toxoplasmosis are estimated to be 400–4000 
per year in the United States (23). The incidence of Toxoplasma-related ocular disease 
is estimated to be up to 1.26 million cases per year (24). However, the seroprevalence 
in several countries has been reduced in the past decade, including the USA, 9% 
seroprevalence was found between 1999-2004 compared to 1988-1994 (22.5%) (25).  
 
In animals, T. gondii can cause disease in domestic livestock, companion animals, and 
wildlife including marine mammals. Toxoplasmosis is one of the major causes of 
abortion in sheep and goats in many countries, leading to economic and agricultural 
losses (26, 27). While Toxoplasma can cause epidemics of ovine abortion, clinical 
toxoplasmosis in cattles and horses has not yet been reported (1). Chronic 
toxoplasmosis is reported to alter behaviour in mice and rats by converting their 
aversion to feline odors into attraction, hence increasing the susceptibility of infected 
rodents to predation by cats. The loss of fear appears to be specific since other 
behaviours are not affected (28, 29). In dogs, clinical toxoplasmosis is reported to be  
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associated with canine distemper virus (CDV) infection probably due to the massive 
immunosuppression associated with CDV. However, the incidence of T. gondii seems 
to have decreased because of routine canine distemper vaccination (30). Recently, an 
increased incidence of toxoplasmosis in a variety of marine mammals such as sea 
otters, seals, and Atlantic bottlenose dolphins has been reported (31-33). Also, T. 
gondii oocysts were found entrapped within Eastern oysters and were found to be the 
cause of infection in otters (34). This evidence suggests that T. gondii oocysts pollute 
the marine ecosystem through contaminated freshwater runoff, as the seroprevalence 
in otters living in areas of maximal freshwater runoff are higher compared to the ones 
living in the areas of low flow (33).  
 
In humans, acute infection in immunocompetent individuals is usually asymptomatic, 
although lymphadenopathy can be observed in some cases (35). In major contrast, if 
Toxoplasma infection occurs during gestation or in immunocompromised individuals 
such as HIV-infected patients or organ/bone marrow transplant patients undergoing 
immunosuppressive drug treatment, the consequences of infection is life-threatening. 
In congenital transmission, fetuses become parasite-positive as a result of maternal 
acquisition of T. gondii for the first time during pregnancy. Tachyzoites enter the fetal 
circulation through placental infection, which can have lethal consequences depending 
upon the stage of gestation during which infection is acquired. Early maternal 
infection in the first and second trimester may result in death of the fetus in utero and 
spontaneous abortion, whereas infection in the last trimester normally results in 
subclinical disease in the newborn but later development of adverse sequelae such as 
retinochoroiditis, blindness, hydrocephalus and mental retardation (36-38). However, 
when infection occurs in seropositive women during pregnancy, the risk to the fetus is 
minimal (39, 40). In immunocompromised individuals, reactivation of cysts during 
 7 
chronic infection causes severe toxoplasmic encephalitis which is the most common 
manifestation in AIDS patients (41). In addition, seronegative patients may acquire  
Toxoplasma through transplanted organs of seropositive donors (42) 
 
T. gondii infection can be diagnosed indirectly by serological methods or directly by 
detection of the parasite. After the first two weeks of infection and throughout the 
lifetime of the infected host, immunoglobulin G (IgG) can be detected by several 
techniques including the Sabin-Feldman dye test, IgG avidity test and agglutination, 
immunofluorescent antibody test, and ELISA (43-48). For IgM detection, the IgM 
immunosorbent agglutination assay (ISAGA) is useful for diagnosis of congenital 
toxoplasmosis in the cord blood or infant serum, since the maternal IgM molecule is 
too large to cross the blood-placenta barrier to the fetus  (49, 50). For direct detection 
of the parasite, PCR of the highly repetitive B1 Toxoplasma gene has been developed 
to detect prenatal toxoplasmosis in amniotic fluids (51). 
 
Standard therapy for toxoplasmosis is the combination of pyrimethamine, sulfadiazine 
and folinic acid. Spiramycin is recommended for use during maternal infection 
especially during the first and second trimester, or in combination with 
pyrimethamine/sulfadiazine for treatment during the third semester (18, 52). However, 
development of new and better anti-Toxoplasma drugs is required to overcome drug 
hypersensitivity reactions that occur in some patients (53). 
 
The development of effective anti-Toxoplasma vaccines is an area of ongoing interest. 
Experimental vaccines have been developed using the parasite protein SAG-1 (p30) as 
well as the secreted microneme protein MIC3 (54-56). The trend in vaccine 
development for this parasite is centered on enhancing T helper type 1 (Th1) responses 
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by producing DNA vaccines or by genetic manipulation of parasite genes to generate 
attenuated strains that induce life-long immunity similar to that induced during the 
natural infection (57, 58). However, no commercially available vaccine has been 
succesfully approved for use in humans yet. The only vaccine licensed is attenuated 
live tachyzoite S48 strain for use in sheep to reduce the rate of abortion (59). 
 
3. Immunology of T. gondii infection 
Toxoplasma is well known for its ability to elicit robust protective Th1 cell-mediated 
immune responses characterized by high amounts of interferon-γ (IFN-γ). Loss of the 
IFN-γ protective response causes reactivation of cysts in chronically infected 
immunocompromised hosts during both human infection and in experimental animal 
models (60, 61). The development of toxoplasmic encephalitis during chronic 
infection was demonstrated by simultaneous depletion of CD4 and CD8 T cells, 
implicating a requirement for both cell types to prevent reactivation of chronic 
infection (62).  
 
Although cell-mediated immunity is essential in disease resistance to T. gondii 
infection, humoral immunity also plays a role. In the absence of circulating antibody 
(Ab), µMT (B-cell deficient) mice survive acute infection but succumb later with high 
parasite burden in the brain and lung. Administration of anti-T. gondii IgG prolongs 
their survival suggesting that protective antibodies are important in increased survival 
(63). Support for this view comes from another study revealing a role for IgM in 
limiting parasite dissemination during acute T. gondii infection by utilizing IgM 
knockout mice (64).  
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Th1 response initiation has been much studied in the context of Toxoplasma infection. 
Early induction of interleukin-12 (IL-12) is an important trigger for IFN-γ-dependent 
control of parasite replication and is required to promote disease resistance (Fig. 1.2). 
The importance of IFN-γ, released from CD4+ and CD8+ T lymphocytes, in mediating 
resistance to T. gondii infection has been established by both antibody-mediated 
depletion and adoptive transfer studies (62, 65-68).  In the absence of endogenous 
IFN-γ, the IL-12 response is not impaired, but the animals rapidly succumb to the 
infection with uncontrolled parasite replication (69). On the other hand, in IL-12 
knockout mice, IFN-γ production is impaired and the animals rapidly succumb to 
infection. These results provide evidence that IL-12 is necessary in vivo to drive 
production of IFN-γ, which in turn allows animals to control the parasite and survive 
infection (70, 71). Direct proof that these cytokines mediate protection come from 
studies showing that administration of recombinant IL-12 and IFN-γ prolongs survival 
of infected mice (72, 73).  In addition to its role during initiation of immunity, IL-12 is 
required for long-term maintenance of IFN-γ-dependent resistance against T. gondii 
infection (60). 
 
Early studies employing severe combined immunodeficiency (SCID) mice that lack T 
and B cells led to the discovery that natural killer (NK) cells were also a source of  IL-
12-dependent IFN-γ during infection with Toxoplasma and other microbial pathogens 
such as Listeria monocytogenes and Leishmania major. For T. gondii, while NK cells 
can provide limited early protection in the absence of T lymphocytes, mice ultimately 
succumb to chronic infection (66, 74, 75). 
 
Dendritic cells (DCs), macrophages and neutrophils are innate immune cells 
responsible for IL-12 production in response to T. gondii infection (76). Murine DCs  
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Figure 1.2. Immune response during T. gondii infection. Upon recognition of 
parasites, innate immune cells including dendritic cells (DC), neutrophils (PMN), and 
macrophages (Mø) release interleukin-12 (IL-12). This cytokine activates natural 
killer cells (NK), CD4+ and CD8+ T lymphocytes to produce interferon-gamma (IFN-γ) 
which, in turn, promote anti-toxoplasma effects through generation of nitric oxide, and 
induction of p47 GTPases including IGTP and LRG-47. 
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are believed to be the major source of T. gondii-induced IL-12 production in vivo 
without the need of IFN-γ priming or costimulation (77, 78). Studies with 
Toxoplasma-infected IL-12-enhanced green fluorescent protein (EGFP) reporter mice 
support this model (Egan and Denkers, unpublished). However, CD40/CD40L 
interaction is required for T. gondii-mediated IL-12 production in human DCs (79). 
Upon parasite recognition, DCs have been implicated in both initiating the IL-12-
mediated IFN-γ response and presentation of parasite-derived antigen to MHC-
restricted T cells. Infection with T. gondii resulted in DC activation based on high 
expression of activation-associated molecules including MHC class II, CD80, CD86, 
and CD40 on both CD8α- and CD8α+ splenic DC and IL-12 production (80). There 
are several subsets of DCs identified. Recent evidence suggests that plasmacytoid DCs 
(usually associated with virus-induced production of Type 1 IFN) also produce high 
level of IL-12 dependent on Toll-like receptor (TLR) 11 (81). Also, IFN-γ-activated 
dendritic cells have been shown to serve as effector cells by inhibiting replication of 
Toxoplasma (82). Thus, in response to Toxoplasma, DC can produce IL-12, present 
antigen to T cells, and may be able to directly kill the parasite. 
 
Macrophages are also an important source of IL-12 production upon parasite 
recognition hence bridging the innate and adaptive immunity (72, 83). IFN-γ strongly 
activates macrophages to become potent effector cells with high level antimicrobicidal 
activity. Activated macrophages are capable of engulfing pathogens and rapidly 
degradating them in phagolysosomes. Nitric oxide (NO) production is induced in 
activated macrophage against Toxoplasma in vitro whereas inducible nitric oxide 
synthase (iNOS)-deficient macrophages displayed defective microbicidal activity. 
However, in vivo, iNOS-deficient mice survive acute infection and control parasite 
growth at the site of inoculation suggesting NO-independent mechanisms operating 
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against the parasite during early infection (71). While this result clearly indicates that 
NO is not required for control of acute infection, the same study showed that iNOS 
knockout mice were susceptible to chronic infection. Subsequently, members of the 
IFN-γ-induced family of p47 GTPases have been implicated in resistance to 
intracellular parasite infection. The p47 GTPases IGTP and LRG-47 are required for 
resistance to acute T. gondii infection in vivo since IGTP- or LRG-47-deficient mice 
succumbed with kinetics similar to those of IFN-γ knockout mice (84, 85). IGTP- or 
LRG-47-deficient macrophages exhibited attenuated IFN-γ-induced inhibition of T. 
gondii growth indicating a role for these two molecules in control of parasite growth 
in macrophages (86). While these molecules are clearly important in controlling 
parasite survival in vitro and in vivo, the mechanisms underlying these effects are 
unknown.  
 
Despite the fact that macrophages possess strong antimicrobial activity, these innate 
immune cells serve as a perfect niche for intracellular Toxoplasma replication. There 
are several parasite-mediated subversion mechanisms that are likely to contribute to 
enhanced survival of Toxoplasma inside infected non-activated macrophages (87), and 
there is evidence that the parasite hijacks these cells for use as “Trojan horses” to 
establish infection in the host (88). Macrophage proinflammatory cytokine production 
is actively suppressed by infection with Toxoplasma, and this may allow time for the 
parasite to replicate and disseminate to other cells. When macrophages are infected 
with T. gondii, production of IL-12 and tumor necrosis factor (TNF)-α are suppressed 
within 24 hr in part through the blockade of nuclear factor κB (NFκB) activity (89). T. 
gondii also down-regulates major histocompatibility complex (MHC) II gene 
expression and antigen presentation in bone-marrow derived macrophages by 
interfering with IFN-γ-induced signal transducer and activator of transcription (STAT) 
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1 nuclear translocation (90, 91). Furthermore, T. gondii interferes with pathways 
leading to apoptosis (92). For example, the parasite exploits host Gi-protein-dependent 
phosphatidylinositol (PI) 3-kinase signaling to prevent induction of apoptosis in 
infected macrophages (93). The ability to trigger strong innate and adaptive immue 
responses, yet at the same time suppress certain immune functions in infected cells is 
likely to be key to success of Toxoplasma as a parasitic microorganism. 
 
4. Immunopathology during T. gondii infection: Induction and prevention 
Toxoplasma induces strong Th1 cytokine responses resulting in parasite killing, and 
long-term immunity to reinfection. However, in certain cases uncontrolled production 
of proinflammatory cytokines triggered by infection can cause severe immune-
mediated pathology in addition to tissue damage associated with parasite replication 
and lytic egress (94).  
 
Several studies demonstrate that CD4+ T cells are a major contributor to 
immunopathology during Toxoplasma infection. Early studies showed ameliorated 
pathologic lesions in the brain following antibody-depletion of CD4+ T lymphocytes 
during chronic toxoplasmosis (95). Further support for a role for CD4+ T cells comes 
from an ocular toxoplasmosis model indicating mild inflammatory responses with low 
parasite burden in the eyes of CD4-deficient compared to WT mice after intraocular T. 
gondii infection (96).  The immunopathogenic role of CD4+ T cells was further 
demonstrated by oral infection of C57BL/6 mice with T. gondii. In this case, mice 
develop fatal ileal necrosis dependent upon CD4+ T cell IFN-γ production (97). In 
addition to IFN-γ, TNF-α and nitric oxide were found to contribute to gut pathology 
based on elevated mRNA levels of TNF and iNOS in CD4+ lamina propria 
mononuclear cells of infected mice as well as studies in iNOS and TNF Receptor 
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knockout mice (98). Furthermore, lamina propria CD4+ T cells synergize with 
intestinal epithelial cells to induce inflammatory chemokines including macrophage-
inflammatory protein (MIP)-2, monocyte chemoattractant protein (MCP)-1, MCP-3, 
MIP-1α, MIP-1β and IFN-γ inducible protein (IP)-10 suggesting that CD4+ T cells and 
enterocytes interact to promote inflammation in the intestinal mucosa (99). Together, 
these findings emphasize the adverse effect of proinflammatory cytokines and 
chemokines, in the pathogenesis of Th1 immunopathology during Toxoplasma 
infection. 
 
As an early IFN-γ producer during acute T. gondii infection, NK cells may also play a 
role in immunopathology during Toxoplasma infection. A recent study revealed the 
importance of chemokine receptor CCR5 for immune-mediated pathology and this 
was associated with NK cell trafficking during Toxoplasma infection. In the absence 
of CCR5, hepatic and ileal tissue architecture from infected mice was less affected 
relative to WT mice, and this was associated with a defective NK cell influx into 
infected tissue. Adoptive transfer of NK cells from WT into naive CCR5-/- mice orally 
challenged with T. gondii results in extensive intestinal necrosis, strongly arguing for 
an immunopathogenic role of NK cells via CCR5-mediated recruitment (100). 
Moreover, there is evidence that NKT cells participate in pathological inflammatory 
responses during T. gondii infection in the intestine because NKT cell-deficient mice 
display resistance in lethal ileitis development (101). Thus, in addition to CD4+ T cells, 
NK and NKT cells are also implicated in T. gondii-mediated immunopathology. 
 
In addition to IFN-γ, TNF-α, NO and IFN-γ-induced chemokines, IL-12 and IL-18 are 
thought to contribute to immune-mediated gut pathology. Thus, treatment of mice with 
anti-IL-12- or IL-18 antibody following T. gondii oral infection prevents ileal necrosis. 
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However, IL-12, but not IL-18, seems to play the dominant role in controlling parasite 
replication as, higher parasite burdens and early death are observed in IL-12p35/p40, 
but not IL-18 knockout mice (102).  
 
In several key aspects, T. gondii-induced immunopathology resembles human 
inflammatory bowel diseases in which proinflammatory cytokines triggered by 
intestinal flora are thought to play an important role (103). Recent data reveal the 
contribution of commensal intestinal microflora to ileal inflammation during 
Toxoplasma oral infection. Gnotobiotic mice, in which cultivable gut bacteria were 
eliminated, do not develop ileitis following T. gondii infection. This suggests that 
endogenous bacteria exacerbate development of gut immunopathology triggered by T. 
gondii (104). Subsequently, TLR4 signaling was identified as a key event in E. coli 
recognition following T. gondii infection based on improved gut pathology in TLR4-/- 
mice as well as polymyxin B treatment to eliminate bacterial lipopolysaccharide in 
WT mice (105). Thus, the bacteria-host interaction appears to be an important player 
in cytokine-dependent immunopathology triggered by Toxoplasma.  
 
While the above studies clearly show that infection can result in overproduction of 
proinflammatory cytokines resulting in immunopathology, it is also clear that the host 
possesses immunoregulatory mechanisms to prevent immune-mediated pathology 
during T. gondii infection. The major anti-inflammatory mediators include the 
cytokines IL-10, IL-27, TGF-β, and the lipid mediator lipoxin. IL-10 is produced by 
macrophages, DC, B cells, Th2 cells and regulatory T cells (106). The significance of 
IL-10 as an immunomodulatory cytokine during T. gondii infection was discovered by 
infecting IL-10-/- mice intraperitoneally with Toxoplasma. IL-10-/- mice succumb 
within 2 weeks and death is associated with extensive liver necrosis as well as highly 
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elevated serum IL-12, IFN-γ and TNF-α. Depletion of CD4+ T cells rescues the 
knockout mice suggesting that IL-10 is dependent upon this cell type (107). There is 
also evidence that IL-10 is involved in protection against gut pathology in Toxoplasma 
resistant mice such as the BALB/c strain, because BALB/c background IL-10 
knockout mice develop intestinal pathology that is similar to the C57BL/6 strain (108). 
The protective role of IL-10 was also demonstrated in an ocular toxoplasmosis model. 
In common with findings in the gut of IL-10-/- mice, intracameral injection with 
Toxoplasma induces cellular infiltration and necrosis in the eye tissues of both mouse 
strains that is increased in severity in the absence of IL-10 (109). Collectively, these 
studies have led to the view that IL-10 is the major anti-inflammatory cytokine that 
protects against immunopathology during Toxoplasma infection. 
 
Nevertheless, other cytokines play a similar role. IL-27 has recently been identified as 
an important regulator of inflammatory cytokines during infection with T. gondii and 
other microbial pathogens. Although this molecule can play a role in inducing Th1 
responses in certain situations, for Toxoplasma infection, IL-27 is required to prevent 
toxoplasmic encephalitis. Thus, in IL-27 Receptor knockout mice, the recently 
identified Th17 T cell subset emerges as a mediator of IL-17-dependent pathology in 
the central nervous system (110). 
 
In addition to IL-10 and IL-27, TGF-β plays role in preventing immunopathology 
during oral Toxoplasma infection. Intraepithelial lymphocytes (IELs) serve as a major 
source of this cytokine. Adoptive transfer of primed IELs prevents the mice from 
severe hemorrhagic enteritis post challenge with Toxoplasma. In addition, depletion of 
TGF-β with antibody results in ileitis in normally resistant mouse strains. Also, co-
culture of antigen-primed IELs with enterocytes in the presence of neutralizing TGF-β 
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antibody results in increased enterocyte inflammatory chemokine production 
supporting a role of TGF-β in downregulating intestinal pathology (111). 
Lipoxin A4 (LXA4), an eicosanoid, is produced during acute T. gondii acute infection. 
This molecule inhibits parasite-induced IL-12 production by inducing a refractory 
state in DCs so that they are unable to generate IL-12. Infection of mice deficient in 5-
lipoxygenase, an enzyme required for LXA4 biosynthesis, results in extensive 
immunopathology indicating an anti-inflammatory role of lipoxin (112, 113). Thus, 
while proinflammatory cytokines are needed to control T. gondii and survive infection, 
the host has multiple mechanisms to regulate production of these potent mediators that 
can themselves be lethal when overproduced. 
5. Neutrophil biology and role during Toxoplasma infection 
Neutrophils are major antimicrobial effectors in the innate immune system. Paul 
Ehrlich first demonstrated this cell type based on staining of multilobular nuclei and 
cytoplasmic granules in 1905. Given the name by neutral cytoplasmic staining with 
basic hematoxylin and acid eosin dyes, neutrophils can be distinguished from other 
granulocytes in which eosinophil and basophil granules are stained in red and blue, 
respectively (114). Neutrophils are the most abundant leukocytes in the blood. 
Although they are terminally differentiated and possess a relatively short lifespan in 
the circulation, vast numbers of polymorphonuclear leukocytes (PMNs) exit the bone 
marrow to enter the circulation, followed by apoptotic death 8-20 hr later. 
Nevertheless, several inflammatory cytokines such as TNF-α, IFN-γ, IL-6, G-CSF 
prolong their lifespan in vitro, suggesting that these cells may be more long-lived 
during infection and inflammation in vivo (115).  
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PMNs serve as the first line of defense by rapidly migrating from the blood circulation 
to the site of infection where they adhere to local capillaries. To transmigrate across 
the endothelial barrier into the tissues requires that vascular endothelium upregulates 
expression of E-selectin in response to inflammatory signals. This provides interaction 
with L-selectin on the neutrophil surface promoting rolling of PMN along the 
endothelium. The β2-integrin CD11b/CD18 on neutrophils further engages endothelial 
adhesion molecules such as ICAM-1 rendering firm adhesion and initiating 
transmigration (116, 117). 
 
Neutrophil development is tightly regulated. Differentiation and maturation of PMNs 
takes place in bone marrow originating from pluripotent hematopoietic stem cells. 
These differentiate into myeloid progenitor cells that are committed to the neutrophilic 
lineage. The different maturation stages leading to mature neutrophils are, in 
progressive order of differentiation: myeloblast, promyelocyte, myelocyte, 
metamyelocyte and band neutrophil which then give rise to mature neutrophil. 
Production of PMNs is stimulated by granulocyte colony-stimulating factor, G-CSF 
(118). During myeloid cell differentiation, neutrophil granules are formed sequentially, 
a process initiated during the early promyelocyte stage and continuing throughout the 
various stages of neutrophil development.  
 
Neutrophils contain three types of granules termed azurophil (primary), specific 
(secondary) and gelatinase (tertiary). The granules are classified according to their 
protein content and differential ability to be exocytosed after neutrophil activation. 
Gelatinase granules are more readily exocytosed than specific granules. Azurophil 
granules undergo limited exocytosis in response to stimulation, instead contributing 
primarily to intracellular degradation of pathogens in the phagolysosome. Azurophil 
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granules are also referred to as peroxidase-positive granules because they are 
characterized by a high content of myeloperoxidase. In addition, azurophil granules 
contain defensins, bactericidal permeability-increasing protein, serine proteases such 
as neutrophil elastase and cathepsin G. Specific granules and gelatinase granules are 
peroxidase-negative. The specific granules are composed of several potent 
antimicrobial substances including lactoferrin, hCAP-18 (a cathelicidin family 
member), and collagenase (matrix metalloprotease-9). Gelatinase granules are 
important primarily as a reservoir of matrix degrading enzymes and membrane 
receptors required during PMN extravasation. As implied by the name, this type of 
granule predominantly contains gelatinase. In addition to these granules, mature 
neutrophils contain secretory vesicles, constituting a reservoir of membrane-associated 
receptors important for the early phase of the neutrophil-mediated inflammatory 
response. Examples include the β2-integrin CD11b/CD18, the formyl-methionyl-
leucyl-phenylalanine (fMLP) receptor and the lipopolysaccharide (LPS)/lipoteichoic 
acid co-receptor CD14 (119, 120). Together, the contents of these cytoplasmic 
granules are important in the antimicrobial arsenal enabling neutrophils to fight 
microbial infection. 
 
The phagocytic function of neutrophils was discovered by Elie Metchnikoff in 1883. 
Neutrophils are extremely efficient at engulfing pathogens into phagosomes which 
fuse with intracellular granules to form a phagolysosome. In the phagolysosomes, 
microorganisms are killed by a combination of oxygen-independent and oxygen-
dependent mechanisms (121). The oxygen-dependent mechanisms involves generation 
of reactive oxygen species, also known as the respiratory burst.  Upon PMN activation, 
assembly of transmembrane and cytosolic subunits of the NADPH oxidase complex is 
formed at the phagosomal membrane leading to electron transfer to molecular oxygen. 
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This process produces superoxide which forms hydrogen peroxide and serves as a 
substrate for myeloperoxidase to generate hypochlorous acid (122). The latter 
molecule is thought to be the most bactericidal oxidant produced by neutrophils (123). 
In humans, the importance of NADPH oxidase has been demonstrated in chronic 
granulomatous disease patients, because inactive NADPH oxidase renders patients 
extremely susceptible to bacterial infections.  
 
In addition to degranulation and NADPH oxidase-mediated intracellular killing, it was 
recently discovered that neutrophil extracellular traps (NETs) contribute to killing of 
extracellular bacteria and pathogenic yeast (124, 125). NETs, released by neutrophils, 
contain granule proteins, DNA and associated histones. In sum, phagocytosis, 
exocytosis of granules or secretory vesicles, production of reactive oxygen species, 
and NETs are important mechanisms for PMN function in killing microbes. 
 
PMNs are also capable of producing several cytokines and chemokines involved in 
recruitment and activation of immune effector cells. A number of studies have 
demonstrated the presence of preformed cytokines and chemokines in PMN, including 
IL-12 and MIP-2 (126, 127). Stimuli such as LPS, fMLP, bacteria and virus infection 
stimulate the release of cytokines and chemokines from neutrophils (128). T. gondii 
also triggers cytokine and chemokine production from PMNs (115). For example, after 
exposure to Toxoplasma soluble lysate antigen, PMNs upregulate expression of  TNF-
α and IL-12 as well as the chemokines MIP-1α and MIP-1β (129, 130). This suggests 
that PMN may be an important source of inflammatory mediators during early 
Toxoplasma infection. 
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Many studies have suggested an essential role for neutrophils in the context of 
bacterial and fungal infection. This is based upon in vivo depletion experiments using 
an antibody against the Gr-1 molecule that is expressed at high levels on PMNs. 
During acute T. gondii infection, Gr-1-depleted mice succumb to infection within two 
weeks, and this is accompanied by failure to induce a protective Th1 response (131, 
132). The latter observation suggests that neutrophils may play a role in immune 
response induction, in addition to being directly microbicidal. However, caution is 
warranted with this interpretation because recent findings reveal that other cell types,  
including DC and monocyte subpopulations, also express Gr-1 (133). 
 
6. Role of mitogen-activated protein kinase pathways in the immune response 
Part of this thesis examines the role of mitogen-activated protein kinases (MAPK) in 
the immune response to T. gondii. In response to a variety of extracellular stimuli, 
these evolutionarily conserved enzymes relay, amplify, and integrate signals from cell 
surface receptors leading to an intracellular cascade resulting in transcriptional or post-
transcriptional regulation of specific target genes. MAPKs are activated by 
phosphorylation, whereas MAPK phosphatases reverse phosphorylation and return the 
MAPK to an inactive state.  
 
The MAPK themselves are the terminal members of a three-component linear kinase 
cascade (Fig. 1.3). The activation loop of MAPK is activated by dual phosphorylation 
on a conserved tripeptide Thr-Xxx-Tyr motif by an upstream MAPK kinase (MKK or 
MAP2K). The MAP2K is activated by dual phosphorylation of an upstream kinase 
termed MKKK or MAP3K. Different upstream signals can lead to activation of 
MAP3K (134, 135). 
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Three major families of MAP kinases have been identified. These are the p38 MAP 
kinases (p38α, p38β, p38γ, p38δ), the extracellular signal regulated protein kinases 
(ERK1, ERK2), and the c-Jun N-terminal kinases (JNK1, JNK2, JNK3). A fourth 
MAPK, ERK5, was later identified (136). These MAPKs are activated by specific 
MAP2K: MEK1/2 for ERK1/2, MKK3/6 for p38, MKK4/7 for JNKs. In turn, these 
MAP2K can be activated by a wide variety of upstream MAP3K, hence creating the 
diversity of MAPK signaling. In addition to this prototypic cascade of MAPK 
activation, p38α MAPK can be autophosphorylated in dependence upon interaction 
with TAB1 (137). 
 
Despite their diverse range of activating stimuli, MAPK signaling cascades confer 
remarkable response specificity. Several mechanisms have been implicated in this 
unique property (135). First, scaffold proteins have been identified for each MAPK 
family (138). These proteins sequester kinases and insulate them from inappropriate 
activation, hence enhancing signaling fidelity. Also, stimulus-selective 
phosphorylation of scaffold proteins determines the components that can bind. For 
example, JIP-1, a scaffold protein for the JNK pathway, ties together MLK1 (a 
MAP3K), MKK7 (a MAP2K), and the MAPK JNK into a specific signaling module 
(139). Second, MAPK have specificity-determining motifs, in addition to the active 
site, to bind with other proteins through highly specific docking sites composed of a 
docking groove, an acidic common docking (CD) and a Glu-Asp (ED) pocket. These 
allow the docking domain (D) of MAPK-interacting proteins to interact with the 
MAPK more specifically. Such proteins include scaffold proteins, substrates, 
MAP2Ks and phosphatases. The crystal structure of p38 MAPK bound to docking 
domains of a p38 substrate and a p38-activating enzyme clearly demonstrate these  
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Figure 1.3. Components of mitogen-activated protein kinase (MAPK) signaling 
pathways. Three families of MAPK include ERK1/2, p38α/β/γ/δ, and JNK1/2/3. A 
fourth MAPK, ERK5 is not shown. Each MAPK family is composed of three modules 
activated in series: MAPKKK, MAPKK, MAPK. The activation of MAPK cascades is  
initiated by diverse stimuli. MAPK is activated by dual phosphorylation on a 
conserved tripeptide motif Thr-Xxx-Tyr by upstream MAPK, which itself is 
phosphorylated by a diverse group of MAPKKK. Upon MAPK activation, it is 
translocated into the nucleus to phosphorylate its downstream substrate. 
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important sites (140). Another mechanism that provides exclusive MAP kinase 
activation is sequential physical interaction between members of a given cascade. For 
example, JNK1/2 is bound by the N-terminal extension of MKK4 which also interacts 
with the catalytic domain of MEKK1. Each interaction is disrupted on activation of 
the downstream kinase (141). 
 
MAPKs play diverse roles in a wide variety of cell functions including cell 
proliferation, cytokine production, cell migration, cell survival and apoptosis. In 
general, it is believed that ERK activation is mainly involved in cell survival and 
proliferation, contributing to neoplasia if the activation is dysregulated. In contrast, 
p38 and JNK MAPK are linked to induction of apoptosis and inflammatory responses, 
implicating them in immune regulation (142). However, the actual roles of each 
MAPK cascade are complex being highly cell type- and context of stimuli-dependent. 
Targeted disruption of MAPK modules through genetic manipulation and use of 
inhibitors provides specific insights into MAP kinase functions (135). 
 
The role of MAPK is a growing area of interest in both innate and adaptive immunity 
(142). In the innate immune response, for example, MKK3 and p38 mediate IL-12 
production in LPS-activated macrophages and CD40L-activated DCs (143). In the 
adaptive immune response, ERK, p38, and JNK have been shown to play several roles 
including early thymocyte development, CD4+ and CD8+ T cell activation and 
differentiation (144). Also, the p38 signaling cascade has been implicated in Th1 
differentiation and cytokine production (145).  
 
JNK is activated primarily by cytokines and exposure to environmental stress such as 
UV irradiation, chemicals, heat or osmotic shock. Activated JNK molecules 
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phosphorylate substrates including transcription factors c-Jun and AP-1. Other 
substrates of JNK includes JunB, JunD, ATF2 and antiapoptotic bcl-2 family members 
(146, 147). In common with p38, JNK is implicated in T-cell activation and IL-2 
expression, as demonstrated in Jurkat T cells (148). Furthermore, CD4+ T cells from 
JNK2 knockout mice fail to differentiate into Th1 cells because of a defect in IFN-γ 
production during early stages of differentiation, suggesting a role of JNK2 in Th1 
development (149).  
 
 
7. Toll-like receptors and their role during T. gondii infection 
The hallmark of host immunity is the ability to distinguish self from non-self to 
combat invading pathogens. To initiate host defense, innate immune cells utilize 
pattern recognition receptors (PRRs) that detect conserved structures among 
microorganisms. These molecular signatures are named pathogen-associated 
molecular patterns (PAMPs). The molecules that possess PAMPs usually have an 
essential role for microbial survival. In mammalian cells, three major PRRs have been 
identified. These are the Toll-like receptors (TLRs), NLR family (NOD and NALPs) 
(150) and RNA helicase retinoic acid inducible gene-I (RIG-I) (151). The latter two 
are intracellular recognition receptors detecting microbial components in the 
cytoplasm such as peptidoglycan or double-stranded RNA, respectively. 
 
TLRs are mammalian homologs of the Toll protein that was originally discovered as a 
determinant of dorsal-ventral polarity during embryogenesis and later as a molecule 
involved in anti-fungal defense in Drosophila (152). To date, 11 human and 13 mouse 
TLRs have been identified. Each TLR recognizes distinct PAMPs derived from 
various microbes, including bacteria, viruses, protozoa and fungi (153-155). TLRs 
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function as a dimer in PAMP recognition. TLR1 and TLR2 form a heterodimer to 
sense bacterial triacylated lipopeptides but TLR2 can also heterodimerize with TLR6 
to recognize bacterial diacylated lipopeptides. Homodimerization occurs with TLR4, 
TLR9 and presumably TLR3 and TLR5 to detect LPS, unmethylated CpG motifs, 
viral dsRNA and bacterial flagellin, respectively (156).  
 
TLRs contain a leucine rich repeat domain and a key cytoplasmic signaling region, 
termed the Toll/IL-1 receptor (TIR) domain (Fig. 1.4). Upon ligand recognition by 
TLR, downstream signaling molecules including the adaptor proteins MyD88, 
TIRAP/Mal, TRIF/TICAM1, and TRAM/TICAM2 mediate the coupling to several 
protein kinases (157). This leads to activation of transcription factors in the NFκB and 
MAPK pathways responsible for proinflammatory cytokine and chemokine production 
as well as co-stimulatory molecule expression on antigen-presenting cells.  
 
Studying the role of TLRs in the context of infectious diseases can be achieved by 
targeted deletion of single or multiple TLRs as well as by using MyD88-/- mice. The 
latter mouse strain has been used extensively to investigate the role of TLRs in 
response to infection since most of TLRs (except TLR3) utilize this adaptor protein. 
However, to interpret results with MyD88 knockout mice, caution should be exercised 
since MyD88 is also a component of the IL-1R family signaling pathway, rendering 
these mice impaired in IL-1- and IL-18-mediated responses (158). Nevertheless, the 
role of TLR signaling has been implicated in several models of infectious disease. For 
example, TLR2, TLR4 and TLR9 are involved in recognition of Mycobacterium 
tuberculosis, Candida albicans, and Trypanosoma cruzi through recognition of 
pathogen lipid associated molecules (159). For the malaria parasite Plasmodium 
falciparum,  recognition appears to occur through TLR9 interaction with hemozoin- 
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Figure 1.4. Toll-like receptor (TLR) recognition of T. gondii.  TLR11 and TLR2/4 
on the surface of innate immune cells specifically recognize T. gondii pathogen 
associated molecular pattern (PAMPs):  profilin and glycosylphosphatidylinositol 
(GPI) protein anchors, respectively. These TLRs function as a dimer in PAMP 
recognition. The ligands are detected  by interacting with the N-terminal leucine-rich 
repeats of TLRs. TLR-ligand interaction triggers the C-terminal Toll-interleukin-1 
receptor (TIR) domain-dependent association with  MyD88 and other adapter proteins 
(not shown). This association recruits members of the IL-1 receptor-associated kinase 
(IRAK) 1 and 4 which are sequentially phosphorylated, causing them to dissociate 
from the receptor complex, then associate with TRAF6. This activates NFκB and 
mitogen-activated protein kinase (MAPK). TLR activation results in expression of 
pro-inflammatory cytokine genes such as IL-12, TNF-α, and IL-6.  
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bound malaria DNA (154, 160). 
 
The role of TLRs in the response to T. gondii has also been studied. In the absence of 
MyD88, intraperitoneally-infected mice succumb to infection associated with high 
parasite load in the peritoneal cavity and defective IL-12 and IFN-γ responses (161). 
Furthermore, interleukin-1β converting enzyme (ICE)-/- mice, lacking functional IL-1 
and IL-18, are able to control T. gondii replication and survive i.p. infection indicating 
that signal transduction through MyD88 is mediated by TLRs, but not IL-1R family 
members (162). Also, during high parasite dose i.p. infection, TLR2-/- mice succumb 
to Toxoplasma, suggesting a role for TLR2 (163). Subsequently, parasite surface 
glycosylphosphatidylinositols (GPIs) were identified as T. gondii ligands for TLR2 
and TLR4 (164). Furthermore, TLR9 knockout were found to be resistant to 
Toxoplasma-induced pathology during oral infection, although whether this was due 
to altered responses to endogenous gut flora or the parasite itself was not determined 
(165). 
 
In addition to the involvement of TLR2, 4, and 9 in the response to Toxoplasma, 
recent studies reveal that a parasite profilin-like protein (TgPRF) serves as a ligand for 
TLR11 (166). This TLR, which is not expressed in humans, was previously 
demonstrated to recognize uropathogenic bacteria (167). In the absence of TLR11, 
mice display increased susceptibility and impaired IL-12 production. In addition, 
TgPRF was further demonstrated to be a TLR11-dependent IL-12 inducer by using a 
genetically engineered Toxoplasma conditional knockout of TgPRF (168). 
Collectively these studies show that multiple TLRs play a role in immunity and 
disease resistance during Toxoplasma infection. 
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 8. Brief outline of dissertation research 
Toxoplasma infection induces strong Th1 immune responses, a response that is largely 
believed to be dependent upon induction of IL-12. During  acute Toxoplasma infection, 
DCs, macrophages and PMNs are major sources of IL-12. Although TLR adaptor 
protein MyD88 is required for PMN IL-12 production during T. gondii infection, the 
downstream MAPK signaling molecules involved have not been investigated.  
 
JNKs have been implicated in both positive and negative regulation of IL-12 
production. Chapter 2 reports the finding that JNK2 is the major JNK/SAPK isoform 
expressed in mouse neutrophils. In addition, this chapter  demonstrates that PMN 
JNK2 is required for IL-12 and MCP-1 production in response to in vitro T. gondii 
stimulation. These findings prompted me to investigate the role of JNK2 in vivo 
during Toxoplasma infection, as described in Chapter 3. To my surprise, I found that 
JNK2 plays role in T. gondii-mediated immunopathology, and in negative regulation 
of IL-12 in vivo. Another signaling molecule that is important in innate immunity, and 
in particular early IL-12 production, is TLR adaptor protein MyD88. Chapter 4 
describes immune responses occurring during oral infection in the absence of MyD88. 
We found that MyD88 signaling is important in PMN recruitment and p47 GTPase 
Irgm3/IGTP expression in intestinal mucosa. Interestingly, while in vivo IL-12 
production was heavily dependent upon MyD88, IFN-γ production reached normal 
levels and mice developed strong protective immunity. Finally, Chapter 5 
summarizes the results and discusses the relevance of the above findings. 
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CHAPTER 2 
MOUSE NEUTROPHILS REQUIRE JNK2 MAPK FOR  
TOXOPLASMA GONDII-INDUCED IL-12p40 AND CCL2/MCP-1 RELEASE* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Reprinted from Woraporn Sukhumavasi, Charlotte E. Egan and Eric Y. Denkers. 
Mouse neutrophils require JNK2 MAPK for Toxoplasma gondii-induced IL-12p40 
and CCL2/MCP-1 release. J. Immunol. 179:3570-3577. Copyright 2007. The 
American Association of Immunologists, Inc. 
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Abstract 
The MAPK family member c-Jun N-terminal kinase (JNK)/stress-activated MAPK 
(SAPK) is involved in extracellular stress and proinflammatory cytokine responses, 
including production of cytokines such as IL-12. The JNK1 and 2 isoforms are widely 
expressed, but JNK3 is largely restricted to tissues of the brain, testis and heart.  In this 
study, we focus on mouse neutrophils, a cell type in which JNK/SAPK expression and 
activity has been given little study. We used Western blot analysis to examine 
expression patterns of JNK/SAPK in wild-type and Jnk2-/- polymorphonuclear 
leukocytes (PMN). Surprisingly, neutrophils displayed a major deficiency in JNK1 
expression, in contrast to macrophages that expressed high levels of both JNK1 and 
JNK2 MAPK. JNK1 expression was steadily reduced during the neutrophil maturation 
in bone marrow. We used PMN infection with the protozoan parasite Toxoplasma 
gondii to determine whether neutrophil JNK2 was functional. The parasite induced 
rapid JNK2 phosphorylation and intracellular FACS staining demonstrated 
preferential activation in infected neutrophils. Use of Jnk2-/- neutrophils revealed that 
this MAPK family member was required for PMN IL-12p40 and CCL2/MCP-1 
production. The chemotactic response displayed a minor JNK2 dependence but 
phagocytosis and oxidative burst activity did not require this MAPK. These findings 
are important because they demonstrate 1) a previously unrecognized unusual JNK 
expression pattern in mouse neutrophils, 2) JNK2 in PMN is activated by Toxoplasma 
invasion and 3) a requirement for JNK2 in PMN IL-12p40 and CCL2/MCP-1 
production in response to a microbial pathogen.    
 
Introduction 
Neutrophils are well-known as acute inflammatory cells that rapidly accumulate in 
high number at sites of infection, largely in response to the chemokine IL-8/CXCL8 in 
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humans and IL-8/CXCL8-like chemokines in mice (1-3). In the classical view of 
polymorphonuclear leukocyte (PMN) function, these cells exert anti-microbial activity 
through phagocytosis, granule exocytosis and production of reactive oxygen 
intermediates (4). This is followed by neutrophil apoptotic death and phagocytic 
removal by macrophages. More recently, neutrophil extracellular traps (NETs) 
composed of chromatin and granule proteins have been reported to contribute to 
killing of extracellular bacteria (5, 6).  
 
Although PMN possess an abbreviated lifespan under steady-state conditions, their 
half-life is extended by cytokines including TNF-α, suggesting that the cells can 
function for extended periods in a proinflammatory milieu (7, 8). Neutrophils 
themselves also produce proinflammatory cytokines and chemokines that can be 
released from preformed stores or produced de novo (9-13). The ability of neutrophils 
to produce immunoregulatory cytokines such as IL-12 and TNF-α suggests that the 
cells play a role in shaping development of the acquired immune response to infection. 
Recent studies have found Ag-bearing PMN in secondary lymphoid organs that have 
the potential to influence generation of Th1 lymphocytes through IL-12 release (14). 
Increasingly, there is evidence for crosstalk between PMN and dendritic cells (15). 
Neutrophils infected with the protozoan parasite Toxoplasma gondii release TNF-α 
which, in turn, activates dendritic cells (9, 16). Similar neutrophil-DC interactions 
occur in humans, and this cross-talk is mediated by direct cell contact and 
glycosylation-dependent interaction between neutrophil MAC-1 and DC-SIGN 
expressed by dendritic cells (17). In addition, DC can acquire antigen from neutrophils 
through direct physical contact for presentation to T lymphocytes (18). These 
combined observations strongly argue for an immunoregulatory function for 
neutrophils, in addition to their well-known microbicidal activity (19).  
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Neutrophils are a source of IL-12 during infection, but little is known regarding 
intracellular signaling molecules involved in PMN production of this cytokine. During 
Toxoplasma infection, the TLR adaptor molecule MyD88 is required for parasite-
induced IL-12 in macrophages, DC and PMN (20). Neutrophils also produce the 
monocyte chemoattractant CCL2/MCP-1, a response dependent upon MyD88 and 
TLR2 (21). Members of the MAPK family influence IL-12 production in cells such as 
macrophages and dendritic cells. In particular, p38 and JNK/stress activated protein 
kinase (SAPK) promote IL-12 production, although in some cases JNK is reported to 
negatively regulate IL-12 (22-25). ERKs 1 and 2 have been implicated in negative 
regulation of IL-12 synthesis in macrophages (22, 23, 26, 27). However, little is 
known regarding MAPK in mouse neutrophil function. 
 
In this study, we investigated JNK/SAPK function in murine PMN. Of the three JNK 
isoforms, JNK1 and JNK2 are widely expressed but JNK3 is limited to tissues of the 
brain, testis and heart (22). Unexpectedly, we found that neutrophil JNK expression is 
largely restricted to JNK2, unlike macrophages which express both JNK1 and JNK2. 
Using PMN from Jnk2-/- mice, we show a major requirement for JNK2 in neutrophil 
IL-12 and CCL2/MCP-1 production. Chemotaxis was partially dependent upon JNK2. 
In contrast, no JNK2 requirement for PMN respiratory burst and phagocytic activity 
was observed. These results reveal novel aspects of MAPK expression in mouse 
neutrophils, and they show a critical contribution of JNK2 in PMN production of 
certain chemokines and cytokines during parasite infection.               
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Materials and Methods 
Mice 
Female C57BL/6 mice 6-8 weeks old were purchased from Charles River Breeding 
Laboratories or Taconic Farms. Homozygous JNK2 knockout mouse (Mapk9tm1Flv) 
breeding pairs were obtained from The Jackson Laboratory.  They were maintained in 
the transgenic mouse core facility at the College of Veterinary Medicine, Cornell 
University (Ithaca, NY), an institution accredited by the American Association for 
Accreditation of Laboratory Animal Care. 
 
Parasites 
T. gondii tachyzoites of the RH strain and transgenic Yellow Fluorescent Protein 
(YFP)-expressing RH tachyzoites (kindly provided by D. Roos, University of 
Pennsylvania)  were passaged in human foreskin fibroblasts twice a week in medium 
consisting of DMEM (Mediatech) supplemented with 1% bovine growth serum 
(Hyclone), 100 U/ml Penicillin and 100 µg/ml Streptomycin (both from Invitrogen 
Life Technologies). Tachyzoites freshly egressed from fibroblasts were washed with 
PBS and resuspended in complete DMEM (cDMEM), consisting of 1 mM sodium 
pyruvate, 0.1 mM nonessential amino acids, 100 U/ml Penicillin, 100 µg/ml 
Streptomycin, 30 mM HEPES (all purchased from Invitrogen Life Technologies),  
10% bovine growth serum and 0.05 mM 2-ME in DMEM. 
 
Mouse  neutrophil isolation 
To obtain neutrophils, mice were intraperitoneally injected with 10% thioglycolate 
(BD Microbiology Systems), then peritoneal exudate cells (PEC; consisting of 60-70% 
PMN) were collected 18 h later. Cells were washed and resuspended in PBS. 
Neutrophils were purified from PEC by continuous Percoll gradient centrifugation. 
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One hundred percent Percoll (Amersham Biosciences) was adjusted to pH 7.4 with 10 
M HCl. The PEC preparation was mixed with the pH-adjusted Percoll at a ratio 1:9, 
then the mixture was transferred to a 10 ml polycarbonate tube (Beckman Coulter). 
Ultracentrifugation was performed at 60,650 x g for 65 min at 4°C with a 50 Ti rotor 
(Beckman Coulter). The neutrophil-enriched layer was harvested using a gel loading 
pipette tip. Cells were washed with PBS and resuspended in cDMEM.  More than 90% 
PMN purity was routinely obtained, as determined by morphology after differential 
staining (Fisher Scientific). PMN viability, monitored by trypan blue exclusion was 
>98%. Cells were counted at least three times to ensure accurate quantitation. 
 
Magnetic labeling of bone marrow cells and cell sorting 
Mouse bone marrow single-cell suspension was prepared followed by magnetic 
labelling with CD11b MicroBeads (Miltenyi Biotec). Positive selection for CD11b+ 
cells was performed twice by autoMACS Separator according to the manufacturer’s 
instruction (Miltenyi Biotec). Enriched-CD11b+ bone marrow cells were then stained 
with PerCP-Cy5.5-conjugated anti-Gr-1 mAb and PE-conjugated anti-CD11b mAb 
(BD Pharmingen). A FACSAria fluorescence-activated cell sorter (BD Biosciences) 
was used to isolate the bone marrow CD11b+ cells into 3 different populations based 
on the surface expression level of CD11b and Gr-1: CD11bint Gr-1int; CD11blow       
Gr-1high; and CD11bhigh Gr1high. 
 
Mouse bone marrow-derived macrophage preparation 
Macrophages were generated from mouse bone marrow in L929 supernatant 
containing M-CSF as described previously (28). 
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Flow cytometry 
For intracellular staining of phosphorylated JNK, YFP-expressing tachyzoites were 
incubated with PEC (15:1 ratio of parasites to cells). At various times, cells were 
transferred to a 96-well plate and washed with ice-cold PBS containing 1% bovine 
growth serum and 0.01% sodium azide (FACS buffer). Samples were fixed with 3% 
paraformaldehyde for 15 min followed by incubation with anti-CD16/32 (2.4G2) to 
block nonspecific antibody binding to FcγRIII/II. Surface staining for Gr-1 was 
performed for 15 min with PerCP-Cy5.5-conjugated anti-Gr-1 mAb (BD Pharmingen). 
For phenotypic analysis of purified neutrophils, cells were co-stained with the 
following PE-conjugated Ab: anti-F4/80 (Invitrogen Life Technologies), anti-CD11c 
(BD Biosciences), anti-CD11b (BD Biosciences), anti-MHC class II (eBioscience), 
anti-CD62L (eBioscience), anti-CD80 (eBioscience), and anti-CD86 (BD Biosciences). 
For intracellular staining of phospho-JNK, cells were permeabilized with 0.075% 
saponin in PBS for 30 min followed by blocking with FACS buffer for 10 min. 
Intracellular staining was accomplished with Alexa Fluor 647-conjugated phospho-
SAPK/JNK (T183/Y185) mouse mAb (Cell Signaling Technology) for 30 min at 
room temperature. Samples were acquired on a FACSCalibur (BD Biosciences) 
cytometer collecting 10,000 Gr-1+ events. Data were analyzed using FlowJo software 
(Tree Star). 
 
Immunoblot Analysis 
PMN and tachyzoites were added to a 24-well plate and infection was synchronized by 
brief centrifugation (550 x g, 3 min, 4ºC). After incubation for various times (37ºC, 
5% CO2), supernatants were removed and cell lysates were prepared for immunoblot 
analysis. Bone marrow-derived macrophages were used as a control for JNK 
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activation by incubation for 20-30 min with 100 ng/ml LPS (Escherichia coli strain 
055:B5; Sigma-Aldrich).  
 
For immunoblot analysis, samples were lysed with SDS-PAGE reducing sample 
buffer and passed through a 27-guage needle three times to reduce sample viscosity. 
Lysates were boiled for 5 min, run on a 10% SDS-PAGE gel, and transferred to a 
nitrocellulose membrane. Membranes were blocked with 3% nonfat dry milk (Nestle)  
in PBS for 20 min. They were probed with a rabbit anti-total JNK polyclonal antibody 
(Upstate Cell Signaling Solutions) or anti-phospho-JNK according to the 
manufacturer’s recommendation (Cell Signaling Technology). HRP-conjugated goat 
anti-rabbit IgG (Cell Signaling Technology) was used as a secondary Ab. Bands were 
visualized by developing with luminol chemiluminescent substrate (Cell Signaling 
Technology) and exposure to autoradiographic film.  
 
Cytokine/chemokine ELISA 
For cytokine protein measurement, neutrophils from WT and Jnk2-/- mice were 
resuspended in cDMEM and plated in a 96-well plate. Tachyzoites were added and 
infection was synchronized by brief centrifugation. The cells were incubated at 37ºC 
in humidified 5% CO2 for varying times, then supernatants were recovered for ELISA. 
Production of IL-12p40 and CCL2/MCP-1 was measured by ELISA as previously 
described (21).  
 
Multiplex bead immunoassay 
Neutrophil supernatants from infected cultures were subjected to Multiplex bead 
immunoassay according to the manufacturer’s instruction (BioSource International). 
The following 19 mouse cytokines and chemokines were measured using a Luminex 
 54 
100 instrument (Qiagen): IL-12p40/p70, CCL2/MCP-1, GM-CSF, IFN-γ, IL-1α, IL-
1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, IFN-γ-inducible protein 10, KC, MIG, 
MIP-1α, TNF-α and vascular endothelial growth factor (VEGF). 
 
Oxidative burst assay  
PMN were stimulated with PMA (200 ng/ml) and fMLP (10-6 M) (EMD Biosciences) 
in the presence of 0.2% NBT (Sigma-Aldrich). After 30 min (37ºC, 5% CO2), cells 
were solubilized with 10% SDS and 0.1 N HCl, then sample OD (570 nm) were 
measured on a spectrophotometer.   
 
Phagocytosis assay 
PMN were incubated (1 h, 37ºC, 5% CO2) with  1 µm fluorescent yellow-green latex 
beads (Sigma-Aldrich) that had been pre-opsonized with normal mouse serum for 1 h. 
Internalization of beads was determined by flow cytometry, using a FACSCalibur (BD 
Biosciences) flow cytometer and data were analyzed with FlowJo software (Tree Star). 
 
Chemotaxis assay 
Assays for chemotaxis used a 96-well chemotaxis chamber (3-µm pore size; 
Neuroprobe). The assay was set up as described previously (16), using 45,000 
neutrophils, the chemoattractants fMLP (10-6 M) and KC (100 ng/ml; AbD Serotec) 
were used in the study. The assay was terminated after 45 min at 37ºC, then the 
number of migrated cells was enumerated by microscopy. 
 
Statistics 
The difference of means was compared using Student’s t test with p < 0.05 considered 
statistically significant. All experiments were repeated at least 2 times.  
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Results 
Isolation of mouse peritoneal neutrophils   
To obtain purified neutrophils for in vitro studies, we elicited peritoneal cell 
recruitment by i.p. injection of 10% thioglycolate and collected exudate cells 18 h later. 
PEC were routinely composed of 60-70% neutrophils and 20-25% macrophages, with 
small numbers of eosinophils, mast cells and lymphocytes (Fig. 2.1A). To purify 
neutrophils, PEC were subjected to ultracentrifugation over a Percoll continuous 
density gradient. This procedure resulted in cell preparations composed of >90% 
neutrophils (Fig. 2.1B). We performed flow cytometry to further assess the phenotype 
of the Gr-1+ neutrophil population. As shown in Fig. 2.1C, the cells expressed high 
levels of CD11b and CD62L, but lacked expression of CD11c and MHC class II. The 
neutrophil population was also negative for F4/80 (data not shown). Interestingly, the 
cells expressed intermediate levels of costimulatory molecule CD86, and low levels of 
CD80. Although we are uncertain as to the functional significance of this result, 
expression of costimulatory molecules by neutrophils isolated from humans has also 
been reported (29, 30).     
 
Diminished expression of JNK1 in mouse neutrophils  
The MAPK family members are implicated in proinflammatory cytokine responses, 
and we previously reported a requirement for JNK in macrophage IL-12 production 
(31). Because neutrophils produce IL-12 during microbial stimulation, we assessed the 
status of JNK1/2 in these cells. Fig. 2.2 shows levels of total JNK in macrophages 
compared to purified neutrophils. As expected, WT macrophages expressed high 
levels of 46- and 54-kDa protein corresponding to JNK1 and JNK2. In marked 
contrast, neutrophils were almost completely devoid of JNK1. JNK3 migrated with a 
mass of 54-kDa, and therefore comigrated with JNK2. However, using neutrophils  
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Figure 2.1. Mouse neutrophils from thioglycolate-elicited peritoneal cells before 
and after purification. A, PEC were obtained by peritoneal lavage with ice-cold PBS 
18 h after i.p. thioglycolate injection. The cells were comprised of 60-70% PMN, 20-
25% macrophages (Mø), low numbers of eosinophils (eos), mast cells (mast) and 
lymphocytes (data not shown). B, PEC were subjected to PMN purification over a 
continuous Percoll gradient immediately following harvest. More than 90% neutrophil 
purity was routinely obtained. C, Purified neutrophils were stained with anti-Gr-1 Ab 
and a panel of cell surface markers. Expression of CD11b, CD11c, CD62L, CD80, 
CD86 and MHC class II (thick black line in each histogram) is shown on the gated Gr-
1+ population relative to staining with isotype controls (thin gray lines in each 
histogram).    
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Figure 2.2. JNK2 is the major JNK/SAPK isoform expressed in mouse 
neutrophils. Total cell lysates of bone marrow-derived macrophage (Mø) and highly 
purified PMN from WT or Jnk2-/- mice were subjected to immunoblot analysis using a 
JNK-specific polyclonal antibody, and an actin-specific antibody as a protein loading 
control. The amount of macrophage and PMN protein loaded was 5, 10, 15 µg/lane. 
Positions of JNK1 and 2 isoforms are marked by arrows. This experiment was 
repeated twice with similar result. MW, Molecular weight marker.  
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from Jnk2-/- mice, we established that the 54-kDa band corresponded to JNK2 protein 
(Fig. 2.2). 
 
Down-regulation of JNK1 during neutrophil maturation 
We next sought to determine where JNK1 expression was down-modulated during 
neutrophil differentiation in the bone marrow. PMN and their precursors in bone 
marrow can be distinguished by morphology and expression of surface markers Gr-1 
and CD11b (32). Accordingly, we enriched for CD11b+ bone marrow cells using 
immunomagnetic beads, then sorted cells into 3 different populations consisting of 
CD11bint Gr-1int, CD11blow Gr-1high, and CD11bhigh Gr1high populations (Fig. 2.3A, a-c, 
respectively). Each population was subjected to Diff-Quick staining (Fig. 2.3B). In 
agreement with previous results (32), the morphology of CD11bint Gr-1int cells was 
consistent with promyelocyte/myelocyte-stage cells (Fig. 2.3B, a) whereas the 
CD11blow Gr-1high and CD11bhigh Gr1high displayed morphology consistent with 
immature PMN and multilobular nucleated mature PMN (Fig. 2.3B, b and c, 
respectively). To examine the expression levels of JNK1 in each population, Western 
blot analysis was performed on protein lysates from the sorted bone marrow cell 
populations, as well as on purified peritoneal neutrophils from WT and Jnk2-/- mice 
and bone marrow-derived macrophages for comparison. Fig. 2.3C shows a steady 
decline in JNK1 and JNK2 expression associated with neutrophil maturation. However, 
based on densitometric analysis, the  decrease in JNK1 was more drastic. Thus, the 
JNK2:JNK1 ratio in promyelocyte/myelocytes, immature PMN, and mature PMN was 
1.9, 3.7 and 7.3, respectively. In elicited neutrophils obtained from the peritoneal 
cavity, the JNK2:JNK1 ratio was 15.8. In contrast, JNK1 was expressed at a higher 
level in macrophages (JNK2:JNK1 = 1.6) and CD11b- bone marrow cells 
(JNK2:JNK1 = 1.7) (Fig. 2.3C).  
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Figure 2.3. JNK expression in wild-type mice during neutrophil maturation. A, 
CD11b+ bone marrow cells were enriched by magnetic sorting then further stained and 
FACS-sorted based on the expression level of CD11b and Gr-1. The gated populations 
define: a, promyelocytes/myelocytes; b, immature neutrophils; and c, mature 
neutrophils. B, Sorted populations a-c were subjected to cytospin and Diff-Quick 
staining to determine the cell morphology. C, Bone marrow (BM) CD11b- cells as 
well as populations a-c were subjected to Western Blot analysis probing with JNK 
polyclonal Ab. These were compared with lysates of bone marrow-derived 
macrophages (Mø)  and WT and Jnk2-/- neutrophils isolated from the peritoneal cavity 
after thioglycolate elicitation. The same membrane was later stripped and reprobed 
with actin Ab. Data shown are representative of two independent experiments.   
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Neutrophil JNK2 is activated during microbial infection 
We used T. gondii, an intracellular pathogen that activates JNK during macrophage 
infection (31, 33), to examine whether neutrophil JNK2 undergoes similar activation. 
Purified PMN were incubated with tachyzoites, and intracellular tachyzoites (an 
average of 1 per cell) were subsequently observed within 20 min of infection (Fig. 
2.4A). At 18 h post-infection, intact intracellular tachyzoites were apparent, although 
rarely more than four per cell (Fig. 2.4B). Absence of any overt signs of parasite death 
or degradation suggests that live tachyzoites actively invade PMN rather than being 
internalized by neutrophil phagocytosis. During infection of PMN, the parasite 
triggered JNK2 phosphorylation and the response was maximal between 20 and 30 
min (Fig. 2.4C).  This result correlates with the kinetics of T. gondii-mediated JNK 
activation in infected bone marrow-derived macrophages (28).  
 
Rapid JNK activation  in T. gondii-infected, but not bystander PMN 
Phosphorylation of neutrophil JNK2 could be induced by secreted products of 
extracellular tachyzoites, by products released during or shortly after invasion, or the 
combination of the two. To address this issue, we used YFP-expressing T. gondii to 
infect PEC that were subsequently stained with anti-Gr-1 Ab. This enabled us to 
distinguish infected and noninfected Gr-1+ populations (Fig. 2.5, A and B). To 
examine the JNK2 phosphorylation in each population, intracellular phospho-specific 
JNK staining was also performed. The intensity of phosphorylation between infected 
and noninfected Gr-1+ PMN (thick lined-boxes in Fig. 2.5B) was compared with Gr-1+ 
neutrophils unexposed to parasites (thin-lined box in Fig. 2.5A). Interestingly, JNK 
phosphorylation occurred predominantly in infected neutrophils, with little or no 
activation in the bystander noninfected population (Fig. 2.5C). In this situation,  
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Figure 2.4. T. gondii infection and activation of JNK in mouse neutrophils. 
Neutrophils were infected with tachyzoites, and cells were examined  20 min (A) and 
18 h post-infection (B).  C, PMN were stimulated with tachyzoites for the period of 
time indicated. Cell lysates were subjected to immunoblot analysis probing with 
polyclonal antibody specific for phospho-JNK (p-JNK). The membrane was then 
stripped and reprobed with total JNK Ab. LPS-stimulated bone marrow-derived 
macrophages were used as a positive control for JNK activation. Data shown are 
representative of three independent experiments. 
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Figure 2.5. JNK activation occurs predominantly in T. gondii infected-Gr-1+ 
PMN. A and B, Use of YFP-expressing tachyzoites allows identification of infected 
and noninfected PMN. Thioglycolate elicited PEC were stained with anti-Gr-1 Ab in 
the absence of tachyzoite (TZ) infection (A). Alternatively, cells were infected, and 
flow cytometric analysis performed 20 min post-infection (B). C, infected (rectangle in 
B) and noninfected (square in B) neutrophils were subjected to phospho-specific JNK 
staining and analyzed by flow cytometry at the indicated time points (min) after in 
vitro infection. The thick lines show phospho-JNK staining in infected and 
noninfected populations compared with phospho-JNK staining in PMN not exposed to 
parasites (thin line in C, and area defined in A). This experiment was repeated three 
times with equivalent results.  
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activation occurred with rapid kinetics, reaching maximal levels at 20 min then 
shifting back to basal level by 30 min postinfection.  
 
T. gondii-induced IL-12p40 and CCL2/MCP-1 production in mouse PMN 
requires JNK2 
Previously, we found that PMN produce both IL-12p40 and CCL2/MCP-1 in response 
to Toxoplasma (21).  Therefore, we examined the role of JNK2 in production of these 
mediators of inflammation. Neutrophils from WT and Jnk2-/- mice were incubated 
with T. gondii tachyzoites at a multiplicity of infection 0.5:1 and supernatants were 
subsequently collected for ELISA. In WT PMN, IL-12p40 production was detectable 
at 4 hours, then peaked and maintained at ~1.6 ng/ml for up to 21 hours (Fig. 2.6A). 
The kinetics of CCL2 production differed, in that this chemokine was not detected 
until 8 hours post-infection, and its production increased steadily throughout the time 
course (Fig. 2.6B). These results are consistent with our previous data suggesting that 
IL-12p40 and CCL2/MCP-1 production during T. gondii infection are independently 
regulated (21). In sharp contrast to the behavior of WT neutrophils, Jnk2-/- PMN failed 
to produce detectable levels of either IL-12p40 or CCL2/MCP-1 (Fig. 2.6). We 
extended these studies by using a Multiplex Bead Immunoassay to assay neutrophil 
supernatants for 19 cytokines and chemokines (listed in Material and Methods). In this 
assay, we confirmed that Toxoplasma stimulates JNK2-dependent IL-12 and 
CCL2/MCP-1. In addition, we found that the neutrophils release MIP-1α and VEGF 
in a manner largely independent of infection and , more importantly, without a 
requirement for JNK2  (Fig. 2.6C).  
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Figure 2.6. JNK2 is required for T. gondii mediated IL-12p40 and CCL2/MCP-1 
production. Thioglycolate-elicited, Percoll gradient-purified neutrophils from WT 
and Jnk2-/- mice were incubated with T. gondii at a multiplicity of infection of 0.5:1. 
At the indicated time points, supernatants were collected for measurement of IL-12p40 
(A) and CCL2/MCP-1 (B) production by ELISA. C, Out of 20 cyto/chemokines 
measured from the supernatants by Multiplex Bead Immunoassay, IL-12p40, 
CCL2/MCP-1, MIP-1α, and VEGF were detected. Med, levels of cytokine/chemokine 
in neutrophil supernatants after culture for 21 h in medium alone. Data shown are 
representative of three independent experiments. 
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Neutrophil respiratory burst, phagocytosis, and chemotaxis in the absence of 
JNK2 
In addition to the role of JNK2 in IL-12p40 and CCL2/MCP-1 production, we asked 
whether this MAPK was involved in other neutrophil functions. To address this 
question, we performed three assays of PMN function, namely, oxidative burst activity, 
phagocytosis, and chemotaxis. As shown in Fig. 2.7A, both WT and Jnk2-/- neutrophils 
produced an equivalent oxidative burst in response to PMA and fMLP. Second, we 
determined the ability of WT and Jnk2-/- PMN to phagocytose opsonized 1-µm 
fluorescent beads. As shown in Fig. 2.7B, WT and Jnk2-/- neutrophils were able to 
phagocytose the beads to the same extent (WT neutrophils, 78% bead-positive;     
Jnk2-/- neutrophils, 82% bead-positive). In these experiments, we confirmed by 
microscopy that cell-associated fluorescence reflected internalization of microbeads 
rather than simple adsorption to the neutrophil surface (Fig. 2.7B, inset). Third, we 
used fMLP and the IL-8-related chemokine KC to induce PMN chemotaxis across a 
transwell membrane. As shown in Fig. 2.7C, there was a minor decrease in fMLP-
stimulated transmigration in the absence of JNK2 that was not statistically significant 
(p = 0.07). However, although KC induced weaker chemotaxis, the response was 
reduced by ~50% in the absence of JNK2 (p < 0.01). In sum, we could not detect a 
requirement for JNK2 in neutrophil phagocytosis or oxidative burst, but there was a 
partial requirement for this MAPK molecule in neutrophil chemotaxis. 
 
Discussion 
The results of this study demonstrate that expression pattern of JNK molecules in 
mouse PMN is almost completely restricted to JNK2. This contrasts with macrophages, 
which express both JNK1 and JNK2. We were able to trace down-regulation of JNK1 
protein during development of neutrophils through promyelocyte/myelocyte stages to  
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Figure 2.7. Neutrophil oxidative burst, phagocytosis and chemotaxis proceed 
normally in the absence of JNK2. A, Oxidative burst. PMN were stimulated with 
PMA (0.2µg/ml) and fMLP (10-6 M) along with NBT solution for 20 min at 37ºC. 
Cells were solubilized in 10%SDS 0.1N HCl. OD was measured at 570 nm. B, 
Phagocytosis. PMN were incubated 1 h with 1 µm green fluorescent beads precoated 
with normal mouse serum. FACS analysis was used to examine phagocytosis of beads 
by PMN. Inset, bead-phagocytosed PMN. C, Chemotaxis. PMN were cultured in a 3-
µm pore transwell membrane in contact with fMLP (10-6 M) and KC (100 ng/ml) in 
the lower chamber. Number of migrated cells was determined after 40 min by 
counting under the microscope at least 3 different high power fields (HPF). Each of 
these experiments was performed twice with the same result. *, p = 0.07 and **, p < 
0.01 (WT vs JNK2 knockout). Each of these experiments was performed twice with 
the same result. 
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immature neutrophils to mature neutrophils in the bone marrow. Infection of PMN 
with T. gondii resulted in JNK2 phosphorylation in a manner kinetically similar to that 
occurring in macrophages. Using PMN isolated from Jnk2-/- mice, which are devoid of 
all JNK isoforms, we demonstrated a requirement for JNK2 in infection-induced IL-
12p40 and CCL2/MCP-1 production. Nevertheless, production of MIP-1α and 
VEGF was normal in the absence of JNK2. We detected a partial JNK2 requirement in 
the neutrophil chemotactic response and indeed others have also found involvement of 
JNK in neutrophil chemotaxis (34, 35) 
 
We previously reported that Toxoplasma induces both IL-12p40 and CCL2 in mouse 
neutrophils (21, 36). The importance of IL-12 during infection with this opportunistic 
pathogen has long been recognized (37, 38). Absence of IL-12 results in uncontrolled 
parasite proliferation and death of the host. More recent data suggests that this is the 
result of Th1 cell secretion of IL-10, rather than complete failure to generate IFN-γ-
positive Th1 T lymphocytes as originally proposed (39). The role of CCL2 during T. 
gondii infection is currently under investigation. However, the chemokine appears to 
be involved in recruiting a novel population of Gr-1+ monocytes capable of 
microbicidal activity against Toxoplasma and other intracellular pathogens (40, 41). 
The importance of these cells is suggested by the finding that mice lacking CCR2, the 
receptor for CCL2, are susceptible to T. gondii (40).  
 
In the absence of an Ab capable of specifically depleting neutrophils in vivo, or 
neutrophil-specific cytokine/chemokine knockout mice, it is difficult to directly 
address the role of neutrophil-derived cytokines and chemokines such as IL-12 and 
CCL2 in the innate response to infection. Nevertheless, PMN accumulate at high 
numbers at sites of infection and in secondary lymphoid organs during the early 
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response to Toxoplasma (42). Given the fact that neutrophils produce a large battery of 
cytokines and chemokines during in vitro stimulation with Toxoplasma and other 
stimuli (11, 13), it seems likely that production of these mediators plays a role in the 
outcome of infection in vivo, either through direct effects on T lymphocytes or by 
influencing other immune effectors such as dendritic cells (16-18).         
 
This study is the first to demonstrate a requirement for JNK in mouse neutrophil IL-
12p40 and CCL2 production. Previously, we reported that neutrophil production of 
both mediators, like production of IL-12 by dendritic cells and macrophages, is 
dependent upon TLR adaptor molecule MyD88 (20, 21). We found that TLR2 was 
required for CCL2 induction, and indeed others have reported that absence of this 
TLR increases susceptibility to T. gondii (21, 43). Interestingly, neutrophil IL-12 did 
not require TLR2. It is possible that TLR11, recently identified as a mouse receptor 
for parasite profilin involved in DC IL-12 production (44), also drives neutrophil IL-
12 release. Further evidence that regulation of IL-12 and CCL2 differs in neutrophils 
comes from the combined findings that IL-10 down-regulates IL-12 but not CCL2 and 
an IFN-γ-STAT1 pathway induces CCL2 but not IL-12p40 secretion (21). In the 
present study, circumstantial evidence for independent regulation comes from the 
disparate kinetics of IL-12 and CCL2 release during neutrophil infection (Fig. 2.6).          
 
Although we did not examine responses of human neutrophils, other studies suggest 
that JNK/SAPK is regulated differently than in mouse PMN. Several reports indicate 
presence of JNK1 in human neutrophils, although it has also been reported that JNK2 
is the dominant isoform in these cells (45-49). More interestingly, it has been reported 
that inflammatory cytokine production in human PMN is independent of JNK and the 
downstream transcription factor complex AP-1 (50). Although this particular study did 
 69 
not specifically examine either IL-12p40 or CCL2, a variety of PMN chemical 
activation stimuli failed to induce nuclear translocation of JNK or activation of 
downstream Jun/Fos proteins. Nevertheless, we note that another group reported a 
JNK requirement for CCL2 production by human PMN (46), a result in line with our 
findings here. 
 
In several infection models there is evidence that JNK1 and JNK2 fulfill distinct 
functions in the immune response. For example, JNK1 is involved in activated T cell 
survival during infection with lymphocytic choriomeningitis virus, whereas JNK2 
controls proliferation of virus-specific CD8+ T lymphocytes (51, 52). The concept that 
there are noncompensatory functions for JNK1 and JNK2 is also suggested by reports 
that Th1 effector cell generation is defective in the absence of JNK2, and that lack of 
JNK1 confers susceptibility to Leishmania major (53, 54). Interestingly, a recent 
report implicated JNK2 in the response to Plasmodium falciparum 
glycosylphosphatidylinositol and pathogenesis of cerebral malaria (55). There is also 
evidence for complex interplay between JNK1 and JNK2 insofar as JNK2 has been 
reported to bind to c-Jun inducing its degradation, whereas JNK1 functions as the 
major c-Jun kinase following cell stimulation (56). Collectively, these studies indicate 
nonredundant functional roles for JNK molecules in the immune system. 
 
In the absence of an ability to artificially enforce JNK1 expression in neutrophils, it is 
difficult to determine why this MAPK family member is down-regulated during the 
neutrophil differentiation program. Neutrophils are well known to be preprogrammed 
for accelerated apoptotic cell death, a response largely unique to this cell type. 
Although some studies indicate a role for JNK in promoting programmed cell death 
(57, 58), others indicate that JNK signaling suppresses apoptosis (59-61). Therefore, it 
 70 
is possible that down-modulation of JNK1 could be involved in promoting an 
apoptotic death program in neutrophils.      
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Abstract 
The function of mitogen-activated protein kinase (MAPK) family member c-Jun N-
terminal kinase (JNK)-2 in resistance and pathology during infection has not been 
greatly studied. Here, we employed Jnk2-/- mice to investigate the role of JNK2 in 
resistance and immunity during oral infection with the protozoan pathogen 
Toxoplasma gondii. We found increased host resistance in the absence of JNK2 as 
determined by lower parasite burden and increased host survival. Lack of JNK2 also 
correlated with decreased neutrophil recruitment to the intestinal mucosa and less 
pathology in the small intestine. In the absence of JNK2, IL-12 production was 
slightly but significantly increased in restimulated splenocyte populations as well as in 
purified splenic dendritic cell cultures. These results provide evidence that expression 
of JNK2 plays a role in T. gondii-induced immunopathology, at the same time in 
promoting susceptibility to this parasitic pathogen.  
 
Introduction 
The intracellular protozoan parasite Toxoplasma gondii infects humans and other 
warm-blooded animals (1, 2). Within the host, the parasite is capable of infecting a 
wide range of hematopoeitic and nonhematopoietic cells. Infection is normally 
asymptomatic, resulting in life-long infection associated with quiescent cysts in the 
brain and skeletal muscle tissue. However, toxoplasmic encephalitis may emerge as a 
life-threatening condition in immunocompromised populations, and congenital 
infection can have severe consequences to the fetus including birth defects and 
abortion, as well as major sequelae of infection later in life (3, 4).  
 
Under normal circumstances, Toxoplasma elicits robust protective immunity that is 
likely to underlie the normally asymptomatic nature of infection. Induction of host 
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resistance to T. gondii requires early stimulation of IL-12 production from innate 
immune cells leading to IFN-γ-dependent control of parasite replication (5, 6). The 
importance of IFN-γ and IL-12 for disease resistance has been most clearly 
demonstrated using IFN-γ and IL-12 knockout mice, as well as in Stat1 and Stat6 
knockout animals, all of which uniformly succumb within 7-10 days of infection due 
to overwhelming parasite replication and dissemination (7-10). However, unregulated 
production of these same cytokines can be detrimental to the host, a situation leading 
to immunopathology and sometimes death of the host (11, 12). A striking example of 
this phenomenon occurs during oral infection of the C57BL/6 mouse strain, which 
develop severe ileal necrosis mediated by CD4+ T cell IFN-γ overproduction (13-15).  
 
The role of host cell signal transduction in immunity to infection is an area of intense 
interest. In particular, the mitogen-activated protein kinase (MAPK) family has been 
demonstrated to control gene expression and immune function, and can play roles in 
positive and negative regulation of proinflammatory cytokine production (16). There 
are three major groups of MAPK in mammalian cells: p38, extracellular signal-
regulated protein kinases (ERK), and c-Jun N-terminal kinases (JNK), also known as 
stress-activated protein kinases (SAPK). The JNK signaling pathway is activated 
primarily by cytokines and exposure to environmental stress, and is believed to play 
important roles in both innate and adaptive immune responses (17-19). Three JNK-
encoding genes have been identified in mammals, namely, JNK1, 2 and 3. JNK1 and 
JNK2 are ubiquitously expressed whereas JNK3 is selectively expressed in neuronal 
tissues. The JNK2 molecule has been implicated in positive and negative regulation of 
IL-12 synthesis, depending on the study, as well as promotion of Th1 and CD8+ T 
lymphocyte responses (20-24). 
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To determine the function of JNK2 in response to Toxoplasma, we recently employed 
Jnk2-/- mice as a source of cells during in vitro infection. We found that while JNK2 
was required for neutrophil production of IL-12p40 and CCL2/MCP-1, macrophage 
IL-12  release did not require this MAPK signaling molecule (25, 26). Here, we 
evaluated the function of JNK2 in immunity and resistance during in vivo infection 
with Toxoplasma. Although we found no major differences in production of IFN-γ in 
the absence of JNK2, dendritic cell IL-12 production was slightly, but significantly, 
elevated in Jnk2-/- animals. Host resistance was increased in the absence of JNK2, and 
this correlated with lower parasite burden in the small intestine and decreased 
neutrophil recruitment into the gut mucosa. In line with these observations, gut 
pathology was alleviated in the absence of JNK2. Thus, while Jnk2-/- mice displayed 
only minor changes in proinflammatory cytokine responses during T. gondii infection, 
deletion of the JNK2 molecule nevertheless promotes resistance to this parasitic 
pathogen. 
 
Materials and Methods 
Mice 
Mapk9tm1Flv (Jnk2-/-) mice on a C57BL/6 background were obtained from the Jackson 
Laboratory (Bar Harbor, ME). A breeding colony was established and genotype 
confirmed by PCR of tail snip DNA according to protocols available from The 
Jackson Laboratory (Fig. 3.1). The animals were maintained under specific-pathogen-
free conditions in the transgenic mouse core facility at the College of Veterinary 
Medicine, Cornell University, overseen by the Institutional Animal Care and Use 
Committee (IACUC). Female progeny between 6-12 wk of age were age-matched 
with C57BL/6 mice (Taconic Farms; Hudson, NY) for experiments.  
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Figure 3.1. Genotypic analysis of WT and Jnk2-/- mice. Primers spanning a portion 
of the Jnk2 gene were used to amplify the predicted 375 and 270 base sequence 
associated with the normal and deleted gene, respectively. Each lane represents an 
individual mouse. 
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Parasites and infections 
Cysts of the low virulence ME49 strain were harvested from brains of chronically 
infected Swiss-Webster mice. Infections were initiated by oral gavage or i.p. injection 
in a volume of 0.2 ml in PBS. T. gondii tachyzoites of the RH and PTG strain 
(clonally derived from ME49) were maintained by passaging twice a week on human 
foreskin fibroblast monolayers as described previously (26). A PCR-ELISA-based kit 
(Roche Applied Science, Mannheim, Germany) was used to confirm absence of 
Mycoplasma contamination in the parasite cultures every two months.  
 
Cell culture 
Splenic single cell suspensions were prepared by lysing red blood cells using red 
blood cell lysing buffer (Sigma-Aldrich, St.Louis, MO).  Debris was removed by 
passing the cell suspensions through a 70 µm cell strainer. The cell number and 
viability was determined by trypan blue exclusion. After washing the cells in PBS, 
they were resuspended in DMEM supplemented with 1 mM sodium pyruvate, 0.1 mM 
non-essential amino acids, 100 U/ml Penicillin, 100 µg/ml Streptomycin, 30 mM 
HEPES (all from Invitrogen, Grand Island, NY), 10% bovine growth serum (Hyclone, 
Logan, UT) and 0.05 mM β-mercaptoethanol. The cells were plated in triplicate in 96-
well plates (107/ml). Soluble tachyzoite antigen (STAg), prepared and described 
previously (27), was added for restimulation. The cells were incubated at 37ºC in a 
humidified 5% CO2 incubator for 48 and 72 hr, then supernatants were recovered and 
stored at -20ºC for ELISA.  
 
ELISA 
Production of IL-12p40 and IFN-γ was measured by ELISA as previously described 
(27).  
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Splenic dendritic cell isolation 
Dendritic cells from spleens were magnetically labeled with Pan DC MicroBeads 
(Miltenyi Biotec Inc., Auburn, CA) following the manufacturer’s protocol. Enriched 
DC were isolated employing an autoMACS Separator (Miltenyi Biotec). Cells 
obtained in this manner were routinely 60-70% CD11c positive, as determined by flow 
cytometric analysis. 
 
Histopathological examination and immunohistochemistry 
Tissues were collected, preserved in 10% neutral buffered formalin and submitted to 
the Histology Unit at the College of Veterinary Medicine, Cornell University to be 
embedded in paraffin blocks for H&E staining and immunohistochemistry. Lesions 
were scored in blind manner and graded based on severity of inflammation (minimal, 
mild, moderate, severe), number of inflammatory foci, distribution of inflammation, 
type of inflammatory reaction, severity of necrosis and intensity of T. gondii infection. 
 
Statistical analysis 
Student’s t-test was employed to analyze statistical differences between groups. p 
values < 0.05 were considered significant. Survival curves were analyzed using a 
logrank test. 
 
Results 
Increased resistance to T. gondii in the absence of JNK2 
We previously found a requirement for MAPK family member JNK2 in IL-12p40 
production by mouse neutrophils during in vitro stimulation with T. gondii (26). 
Nevertheless, we also found that production of IL-12p40 by bone marrow-derived 
macrophages did not require JNK2 (25). Because IL-12 is well known to be required 
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for induction of Th1 responses and because this type of immunity is required in host 
defense against Toxoplasma (5, 28), we assessed the role of JNK2 during in vivo 
infection with this pathogen. Surprisingly, in the absence of JNK2, mice were more 
resistant during i.p. infection with the low virulence ME49 T. gondii strain (Fig. 
3.2A). We also inoculated mice by oral gavage to determine if route of infection 
influenced the pattern of susceptibility in the absence of JNK2. Here again, WT 
animals displayed an accelerated rate of death compared to Jnk2 KO mice (Fig. 3.2B). 
We also terminated an i. p. infection experiment at Day 30 post-infection for brain 
cyst enumeration. In line with the survival data, brains of Jnk2 KO mice contained 
fewer cysts than WT counterparts (Fig. 3.2C; p = 0.039).  
 
To determine if the decreased parasite number associated with lack of JNK2 was also 
apparent in the intestine during acute infection, we isolated tissues from orally 
inoculated animals and performed immunohistochemical staining for T. gondii. 
Parasite numbers were elevated in the intestinal mucosa of WT relative to Jnk2 KO 
mice infected with 20 cysts (Fig. 3.3A and B, respectively) as well as with 100 cysts 
(data not shown). Increased parasite numbers were also apparent in Peyer’s patches of 
WT compared to KO animals (Fig. 3.3C and D, respectively) as well as in mesenteric 
lymph nodes (not shown). 
 
Serum cytokine levels during T. gondii infection in WT and Jnk2-/- mice 
We next investigated production of IL-12p40 and IFN-γ, cytokines that together play a 
central role in resistance to Toxoplasma (6, 29). Accordingly, we orally infected mice 
with 20 and 100 ME49 cysts and measured serum cytokine levels on Day 4 and Day 7 
post-infection. Levels of IL-12p40 between WT and KO mice were indistinguishable  
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Figure 3.2. Increased resistance to T. gondii infection in the absence of JNK2. 
Wild-type and Jnk2 knockout mice (n = 5 per group) were infected by i.p. (panel A) or 
oral (panel B) administration of 20 ME49 cysts. At Day 30 after i. p. infection, brains 
were removed from surviving mice and cyst numbers were enumerated  (panel C). *, p 
< 0.05. 
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Figure 3.3. Decreased parasite numbers in Jnk2 KO intestinal tissues during oral 
infection. WT and KO mice were infected with 20 ME49 cysts and 7 days later 
intestinal tissues were isolated, sectioned and subjected to immunohistochemical 
staining for Toxoplasma. Panel A and C shows the parasite staining in WT intestinal 
mucosa and Peyer’s patches, respectively, compared to the KO in panel B and D. 
Scale bar = 200 µm. 
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at both time points during low and high dose infection (Fig. 3.4A and B). Along 
similar lines, serum IFN-γ levels were comparable between the two mouse strains 
(Fig. 3.4C and D). Nevertheless, at Day 4 post-infection with 20 cysts, Jnk2 KO mice 
displayed elevated IFN-γ levels compared to WT animals, although this difference was 
not apparent in the high dose infection.     
 
Splenic IL-12p40 and IFN-γ responses of WT and Jnk2-/- mice during acute 
infection 
In addition to examining the role of JNK2 in IL-12p40 and IFN-γ production at the 
systemic level, we sought to determine whether this MAPK was involved in the 
splenic cytokine response during infection. We found a slight but significant increase 
in IL-12 production in cells from uninfected, as well as Day 4 and Day 7-infected KO 
mice relative to WT counterparts (Fig. 3.5A and B). There was also a trend in 
increased IFN-γ production by KO cells, although differences between WT and KO 
were minor (Fig. 3.5C and D). We also examined responses of mesenteric lymph node 
cells but could not find any consistent differences between WT and KO mice over the 
course of several experiments (data not shown).  
 
Parasite-induced IL-12p40 induction in splenic CD11c+ cells from wild-type and 
Jnk2-/- mice 
Splenocyte IL-12 production during T. gondii infection is believed to derive in large 
part from resident DC responding to parasite profilin, a ligand of Toll-like receptor 11 
(30-32). To examine the role of JNK2 in DC responses to Toxoplasma, we employed 
immunomagnetic labeling to isolate an enriched population of CD11c+ cells from 
spleens of noninfected mice, which were then cultured with STAg, as well as live RH 
and PTG (clonally derived from ME49) strain tachyzoites. As shown in Fig. 3.6, and  
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Figure 3.4. Serum cytokine response during T. gondii infection in wild-type and 
Jnk2-/- mice. Mice were orally infected with 20 (panels A and C) or 100 (panels B and 
D) cysts and serum was collected from individual mice for IL-12p40 (A and B) and 
IFN-γ (C and D) ELISA. The data shown are the mean ± SD of triplicate samples. 
These results were repeated twice with the same result. *, p < 0.05.  
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Figure 3.5. Splenic IL-12p40 and IFN-γ responses of wild-type and Jnk2-/- mice 
during acute infection. Mice were orally infected with 20 (A and C) or 100 (B and D) 
Toxoplasma cysts. Splenocytes were prepared at the indicated times post-infection and 
cultured with soluble tachyzoite antigen (3 µg/ml). Supernatants were subsequently 
collected for IL-12p40 (A and B) and IFN-γ (C and D) ELISA. The data shown are the 
mean ± SD of triplicate samples. These results were repeated twice with the same 
result. *, p < 0.05. 
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Figure 3.6. Parasite-induced IL-12p40 induction in splenic CD11c+ cells from 
wild-type and Jnk2-/- mice. Following immunomagnetic selection of CD11c+ DC, 
cells were inoculated with type I RH and type II PTG tachyzoites at a multiplicity of 
infection of 0.5:1, or cultured with soluble tachyzoite antigen (25 µg/ml). After 18 hr, 
the supernatants were collected for IL-12p40 ELISA. The data shown are the mean ± 
SD of triplicate samples. These results were repeated twice with the same result.        
*, p < 0.05. 
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consistent with the results using whole splenocyte populations, absence of JNK2 
resulted in a small but significant elevation in IL-12p40 release. 
 
Jnk2-/- mice are resistant to T.gondii-induced ileitis  
Previous studies have established that C57BL/6 mice succumb to severe inflammatory 
pathology in the small intestine after oral infection with T.gondii (13, 15, 33). 
Accordingly, we assessed the role of JNK2 in parasite-induced intestinal damage to 
the gut. As shown in Fig. 3.7A and C, WT mice displayed multifocal areas of 
inflammation and necrosis. In these animals, 50-70% of the small intestine was 
affected, with inflammatory cell infiltration in lamina propria and submucosa. Loss of 
villi tips was also apparent  in some areas (Fig. 3.7C). In contrast, lesions in Jnk2-/- 
were much less severe, with fewer foci of inflammation in the entire intestinal section 
(average of 57 foci in KO compared to 162 foci in WT) (Fig. 3.7B). The intestinal 
architecture was largely intact compared to the WT counterparts (Fig. 3.7D). 
 
Jnk2-/- mice display decreased infiltration of myeloperoxidase-positive cells in 
intestinal tissues  during oral infection 
Our previous data demonstrated a partial requirement for JNK2 in neutrophil 
chemotaxis induced by the IL-8-related chemokine KC in vitro (26). To evaluate the 
role of JNK2 in neutrophil recruitment in vivo, we performed immunohistochemical 
staining for myeloperoxidase (MPO), an enzyme expressed at high level in azurophil 
granules of neutrophils (34). Peyer’s patches of WT animals contained greater 
numbers of MPO-positive cells relative to KO counterparts (Fig. 3.8A and B, 
respectively). Similarly, we found increased numbers of MPO-positive cells in the 
lamina propria and submucosa of intestinal sections in WT (Fig. 3.8C) compared to 
Jnk2 KO mice (Fig. 3.8D). Therefore, expression of JNK2 promotes susceptibility to  
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Figure 3.7. Jnk2-/- mice are resistant to T. gondii-induced ileitis. WT and Jnk2-/- 
mice (2 mice per group) were orally infected with 100 Toxoplasma cysts. At Day 10 
postinfection, the small intestines were harvested, fixed and subjected to H&E 
staining. Low magnification imaging of ileal sections of infected WT mice are shown 
in panel A and B, respectively. The regions delineated by the rectangles were imaged 
at higher magnification in panels C and D. Scale bar = 200 µm. Data shown are one 
representative experiment of two. 
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Figure 3.8. Decreased numbers of MPO-positive cells in the absence of JNK2 in 
intestinal tissues uring oral infection. Small intestines were collected from WT (A 
and C) and  Jnk2-/- (B and D) mice 7 days after oral infection. Sections were then 
subjected to immunohistochemical staining with an anti-MPO polyclonal serum. 
Panels A and B show MPO staining of Peyer’s patches from WT and KO, 
respectively. Panel C and D illustrate MPO staining of WT and KO gut mucosa. Scale 
bar denotes 100 µm.  
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Toxoplasma-induced inflammatory gut pathology, and that this is associated with 
JNK2-dependent neutrophil recruitment to the site of infection. 
 
Discussion 
The function of MAPK family member JNK2 in innate and acquired immunity is 
unclear, and few studies have addressed the role of this molecule during the response 
to infection. In this study we found that mice lacking JNK2 displayed enhanced 
resistance to T. gondii infection initiated by both i. p. and oral infection. During oral 
infection, Jnk2-/- mice were resistant to parasite-mediated damage to the ileum, and the 
animals displayed decreased neutrophil recruitment to the intestinal mucosa. Insofar as 
IL-12 and IFN-γ play central roles in resistance to this parasitic pathogen (5), our 
initial hypothesis was that production of one or another of these two cytokines would 
be upregulated by absence of JNK2-mediated signal transduction. However, for the 
case of IFN-γ, levels of this Th1-associated cytokine were equivalent in WT and KO 
mice undergoing infection. Although IL-12 production by splenocytes as well as 
purified splenic DC was, indeed, higher in the absence of JNK2, the differences were 
marginal and it seems unlikely that this is the cause of increased resistance of Jnk2-/- 
mice.  
 
There is no clear consensus on the role of JNK molecules in IL-12 synthesis. In the 
present study, we found evidence that JNK2 negatively regulates IL-12p40 production 
during infection. In line with these data, others have reported that Gi-protein mediated 
IL-12 downregulation is dependent upon JNK signaling in human monocytes (21). 
Nevertheless, our own recent studies show a requirement for JNK2 in neutrophil IL-12 
production, and it has also been reported that LPS-induced IL-12 production by the 
human promonocytic cell line THP-1 is mediated by JNK signaling (22, 26). Taking 
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these results together, it seems probable that the role of JNK in IL-12 synthesis varies 
depending on cell type and possibly conditions of stimulation. 
 
Initial reports employing Jnk2-/- mice indicated that JNK2 was important for T 
lymphocyte activation (35). It was also suggested that JNK2 expression in CD4+ T 
cells was required for differentiation into Th1 effectors (20). Other more recent studies 
suggest that JNK2 signaling negatively regulates expansion and effector function of 
CD8+ T cells. For example, absence of JNK2 led to increased IL-2 production and 
expansion of virus-specific CD8+ T cells during infection with both influenza virus 
and lymphocytic choriomeningitis virus (36, 37). In an OT-1 system using ovalbumin-
specific CD8+ T cells on a Jnk2-/- background, it was found that CD8+ T cells 
produced increased amounts of IFN-γ and elevated levels of T-bet and eomesodermin, 
transcription factors that are required for effector CTL generation (23). Because 
optimal resistance to Toxoplasma requires IFN-γ production by CD8+ T lymphocytes 
(38-40), it is possible that enhanced CD8+ activity in the absence of JNK2 accounts for 
increased resistance of Jnk2-/- mice. We are currently evaluating the function of CD8+ 
T cells on a Jnk2-/- background during T. gondii infection.      
 
A striking feature of the present results is that intestinal pathology induced by oral 
Toxoplasma infection was alleviated in Jnk2-/- mice. Damage to the gut during T. 
gondii infection is mediated by proinflammatory mediators that include IL-12p40, 
TNF-α, IFN-γ and nitric oxide (13, 15). Nevertheless, IL-12 levels were higher in the 
absence of JNK2, and we could find no consistent difference in TNF-α or IFN-γ levels 
during infection in the absence of JNK2. This was also the case for production of 
nitric oxide (data not shown). Regardless, it is interesting to note that Jnk2 deletion 
has similarly been found to confer resistance to Plasmodium berghei ANKA (41). 
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Infection with the latter induces cerebral pathology that, like oral infection with T. 
gondii, is mediated by proinflammatory cytokines (42, 43). Along similar lines, it was 
recently found that JNK2 deficiency increases resistance to Anaplasma 
phagocytophilum, and this was associated with increased IFN-γ production by natural 
killer (NK) and NKT cells (44). Together, these data point to a role for JNK2 in down-
modulation of proinflammatory responses during microbial infection. 
 
Finally, absence of JNK2 also resulted in defective neutrophil recruitment to the small 
intestine during oral infection. In a previous study, we found that JNK2 signaling was 
required for neutrophil chemotaxis in vitro (26). JNK signaling is also involved in 
neutrophil recruitment to the lung induced by lipopolysaccharide and positive air 
pressure (45, 46). In addition to direct effects on chemotaxis, activation of JNK is 
necessary for neutrophil adhesion to endothelial cells that is involved in recruitment to 
sites of infection or inflammation (47). Whether JNK2-dependent neutrophil 
recruitment during oral Toxoplasma infection contributes to pathology in the gut is 
currently under investigation in our laboratory.   
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CHAPTER 4 
TOLL-LIKE RECEPTOR ADAPTOR MYD88 IS ESSENTIAL FOR 
PATHOGEN CONTROL BUT NOT ADAPTIVE IMMUNITY DURING 
TOXOPLASMA GONDII INFECTION* 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Reprinted from Woraporn Sukhumavasi, Charlotte E. Egan, Amy L. Warren, 
Gregory A. Taylor, Barbara A. Fox, David J. Bzik and Eric Y. Denkers. Submitted for 
publication.
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Abstract 
Toll-like receptor (TLR)/MyD88 activation is important in host resistance to 
Toxoplasma gondii during i. p. infection, but the function of this signaling pathway 
during oral infection, in which mucosal immunity assumes a predominant role, has not 
been examined. Here, we show that MyD88-/- mice fail to control the parasite and 
succumb within two weeks of oral infection. Early during infection, T cell IFN-γ 
production, recruitment of neutrophils and induction of p47 GTPase Irgm3/IGTP in 
the intestinal mucosa were dependent upon functional MyD88. Unexpectedly, these 
responses were MyD88-independent later during acute infection. In particular, CD4+ T 
cell IFN-γ reached normal levels independently of MyD88, despite continued absence 
of IL-12 in these animals. Intraperitoneal vaccination of MyD88-/- mice with an 
avirulent T. gondii uracil axotroph elicited robust IFN-γ responses and protective 
immunity to challenge with a high virulence T. gondii strain. Our results demonstrate 
that MyD88 is required to control Toxoplasma infection, but that the parasite can 
trigger adaptive immunity without the need for this TLR adaptor molecule.          
 
Introduction 
Toll-like receptors (TLR) have emerged as a major family of pattern recognition 
molecules involved in sensing infectious nonself molecules and possibly endogenous 
molecules of the host. There are 11-13 TLR in mice and humans that recognize 
diverse molecules including bacterial lipopolysaccharide, lipopeptides, unmethylated 
CpG oligodinucleotides, as well as single and double-stranded RNA (1, 2). Signaling 
through TLR is complex, but all TLR (with the exception of TLR3) use the adaptor 
molecule MyD88 to initiate intracellular signal transduction (3-5). Most prominent 
among these signaling pathways are NFκB and mitogen-activated protein kinase 
(MAPK) cascades leading to induction of proinflammatory cytokines such as IL-12 
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and TNF-α. MyD88 is also used to relay signals emanating from IL-1 and IL-18 
receptors. As such, MyD88 represents a bottleneck through which most TLR, as well 
as IL-1R/IL-18R, initiated signals must pass.         
 
The importance of MyD88 in infectious disease models has been firmly established 
using genetically engineered MyD88-/- mice. Animals lacking MyD88 display 
decreased resistance to bacteria such as Mycobacterium tuberculosis, Staphyloccus 
aureus, Listeria monocytogenes, and Brucella abortus (6-9). It is also becoming clear 
that TLR and MyD88 are important in the innate immune response to parasitic 
protozoans (10). Thus, MyD88 KO mice are increased in susceptibility to infections 
with Toxoplasma gondii, Plasmodium berghei, Leishmania major and Trypanosoma 
cruzi (11-15). TLR ligands have been identified for several protozoan species, 
including T. gondii, Plasmodium, and T. cruzi (16-18). Nevertheless, while knock out 
of MyD88 may have dramatic effects on resistance to bacterial and protozoan 
infection, inactivation of genes encoding individual TLR often has little or no impact. 
This has led to the view that the response to any given pathogen is likely to involve 
multiple TLR that act in concert to provide optimal resistance to infection (19-21).           
 
There is evidence that TLR-MyD88 signaling is important, not only in innate immune 
responses, but also in initiation of acquired immunity (22). For example, MyD88 
transduced signaling leads to upregulation of costimulatory molecules on DC that is 
required to activate naïve T cells, and T cell antigen-specific responses are optimized 
when microbial peptides are presented within the context of TLR ligands (23, 24). 
Nevertheless, the role of TLR-MyD88 in initiation of adaptive immunity during 
infection with complex pathogens is less certain. In some cases MyD88 is not 
necessary, such as in the generation of Listeria monocytogenes-specific CD8+ T cell 
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responses and during acquired immunity to Borrelia burgdorferi (25-27). In other 
cases, MyD88 seems to play a prominent role in adaptive immunity, for example in 
the humoral immune response to polyoma virus infection and the antiviral CD8+ 
response to lymphocytic choriomeningitis virus (28, 29).  
 
In this study we focus on infection with the intracellular protozoan T. gondii, a 
parasite known for its ability to elicit strong protective Th1 responses, but that causes 
serious disease in immunocompromised individuals (30, 31). It has previously been 
shown that MyD88-/- animals rapidly succumb to Toxoplasma in a model involving i. 
p. injection of parasites (14). TLR signaling is strongly implicated in this situation 
because mice defective in IL-1β-converting enzyme display normal resistance to 
infection despite an inability to produce functional IL-1 or IL-18 (15). Tachyzoite 
profilin and glycosylinositolphosphatidyl lipid moieties have recently been identified 
as parasite ligands of TLR11 and TLR2/4, respectively (32-34). Furthermore, for the 
case of profilin there is evidence that signaling through TLR11 promotes an 
immunodominant T cell response to peptides derived from this molecule (35).  
 
Here, we show that MyD88 is required to survive oral infection with Toxoplasma. 
Early during infection MyD88-/- animals displayed defects in neutrophil recruitment to 
mucosal tissues and induction of Irgm3/IGTP, a molecule required to survive acute 
infection.  Surprisingly, T cell-derived IFN-γ production, a key event in adaptive 
immunity to the parasite, reached normal levels later during acute infection. To test the 
ability of MyD88 KO mice to generate protective immunity to T. gondii we employed 
a genetically engineered avirulent parasite strain that invades but cannot replicate in 
host cells. Vaccination with this mutant elicited fully functional Th1 cell 
differentiation and immunity to challenge infection. Our results show that during T. 
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gondii infection MyD88 signaling is essential for host microbicidal function, but that 
it is dispensable for the adaptive immune response to this intracellular pathogen.      
 
Materials and Methods 
Mice  
Female mice (6-12 wks of age) were used throughout these studies. IL-12p40-/- mice 
and C57BL/6 controls were purchased from The Jackson Laboratory. MyD88+/+ and 
MyD88-/- mice (generated by S. Akira, Osaka University, and kindly provided by Dr. 
E. Pearlman, Case Western Reserve University) were generated by crosses of 
heterozygous mice. To genotype F1 litters, tail snips were lysed in the Lysis Reagent 
with Proteinase K according to the manufacturer’s instructions (Viagen Biotech, Los 
Angeles, CA). DNA in digests were subjected to RT-PCR analysis to determine the 
mouse genotype using a protocol kindly supplied by Dr. E. Pearlman (Case Western 
Reserve University). Primers employed for sequence amplification were 5’-TGG-
CAT-GCC-TCC-ATC-ATA-GTT-AAC-C-3’ (MyD88F), 5’-GTC-AGA-AAC-AAC-
CAC-CAC-CAT-GC-3’ (MyD88R), and 5’-ATC-GCC-TTC-TAT-CGC-CTT-CTT-
GAC-G-3’ (MyD88Neo). WT and KO status of the animals was confirmed after the 
mice were euthanized in experiments.  Littermate female age-matched mice between 
6-12 wk of age were used for experiments. The mice were housed under specific 
pathogen-free conditions at the Transgenic Mouse Facility, College of Veterinary 
Medicine, Cornell University overseen by the Institutional Animal Care and Use 
Committee. 
 
Parasites and Infections  
Cysts of the low virulence ME49 strain were obtained from brains of chronically 
infected Swiss-Webster mice. Oral infections were carried out by intubation with a 
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blunt-ended needle. Except where noted, 20 cysts in a volume of 0.2 ml PBS were 
administered. Tachyzoites of the RH and cps1-1 strain were maintained in vitro on 
human foreskin fibroblasts. For the case of cps1-1, 0.3 mM uracil was added to the 
growth medium. Vaccination with cps1-1 was accomplished by i. p. injections of 2 x 
104, 2 x 105 and 2 x 105 tachyzoites at biweekly intervals. Two weeks after the final 
injection, animals were challenged by subcutaneous injection of 2000 RH strain 
tachyzoites. 
 
Histopathology  
Tissues were collected and preserved in 10% neutral buffered formalin and submitted 
to the Histology Unit, College of Veterinary Medicine, Cornell University to be 
processed into paraffin embedded blocks for H & E staining. Lesions were scored in 
blind manner and graded based on severity of inflammation (minimal, mild, moderate, 
severe), number of inflammatory foci, distribution of inflammation, type of 
inflammatory reaction and severity of necrosis. 
 
Immunohistochemistry  
Sections of formalin-fixed paraffin-embedded tissues were stained with a rabbit anti-
Toxoplasma antiserum by the Histology Unit, College of Veterinary Medicine, Cornell 
University. Other sections were stained with rabbit anti-MPO or rabbit anti-
Irgm3/IGTP (59) using a standard immunoperoxidase staining protocol. Briefly, 
sections were de-paraffinised and rehydrated by serial immersion in xylene and graded 
alcohols, then finally water. Exogenous peroxidase activity was quenched by 
incubation in 0.5% H202 followed by microwave treatment in citrate buffer (0.1 M 
citric acid in PBS, pH 6.0) to unmask antigens. Sections were blocked in 10% normal 
serum in casein blocking reagent (Vector Labs) (20 min, 20°C). Primary antibody was 
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diluted in PBS with casein blocking reagent, and applied to the tissue (2 hrs, 37°C). 
Sections were washed 4 times in PBS with 0.4% Brij (Sigma). A biotinylated 
secondary antibody was diluted in PBS and incubated with the tissue (20 min, 20°C). 
Sections were washed 3 times (PBS with 0.4% Brij). Biotin was detected using 
streptavidin-conjugated peroxidase (20 min, 20°C). Slides were subsequently washed 
3 times (PBS with 0.4% Brij) and visualized with 3-amino-9-ethylcarbazole (AEC) 
chromagen (Vector Labs) (10 min, 20°C). Sections were rinsed in water, 
counterstained in Gill’s Hematoxylin (Vector Labs), mounted and examined by bright-
field microscopy. The specificity of Irgm3/IGTP staining was confirmed by 
examination of tissues from Irgm3/Igtp-/- mice. 
 
Flow cytometry  
For phenotypic analysis of splenocyte and mesenteric lymph node cells, cell surface 
staining was accomplished as previously described (60) using the following 
fluorochrome conjugated mAb: anti-CD11c-PE, anti-Gr-1-PerCP-Cy5.5, anti-B220-
PE, anti-CD8-PE-Cy7, anti-CD4-FITC, anti-CD44-APC (all from BD Pharmingen), 
anti-F480-APC, anti-CD3-APC (all from Invitrogen), anti-CD62L-PE, anti-CD25-PE, 
anti-CD69-PE (all from eBioscience). Intracellular cytokine staining was 
accomplished by incubating single cell suspensions in cDMEM (DMEM 
supplemented with 10% bovine growth serum, 1 mM sodium pyruvate, 0.1 mM 
nonessential amino acids, 0.05 mM β-mercaptoethanol, 100 U/ml penicillin, 100 
µg/ml streptomycin, and 30 mM HEPES) with or without STAg or cps1-1. Golgiplug 
(BD Biosciences) was added for the last 4 hr of culture. Cells were washed and 
surface stained for CD4 and CD8 (20 min, 4°C). Cells were then fixed and 
permeabilized in cytofix/cytoperm solution (BD Biosciences) according to the 
manufacturer’s instructions. Cells were washed in Perm Wash (BD Biosciences) and 
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resuspended in intracellular staining buffer containing 10% normal mouse serum, 10% 
rat IgG and optimal concentrations of fluorochrome-tagged anti-cytokine antibodies in 
Perm Wash (60 min, 4°C). Cells were washed twice in Perm Wash, resuspended in 
FACS buffer and immediately analyzed on a FACScalibur flow cytometer (BD 
Biosciences) collecting at least 50,000 events per sample. Data were subsequently 
analyzed using FlowJo software (Tree Star).  
 
Cell culture  
Single cell suspensions were prepared and red blood cells were removed by using 
RBC lysis buffer according to manufacturer’s protocol (Sigma-Aldrich). Cell debris 
was removed by filtering through a 40 µm cell strainer. Cells were washed with PBS 
and resuspended in cDMEM. Viable cell number was determined by trypan blue 
exclusion. For cytokine protein measurement, cells were plated in a 96-well plate 
(107/ml). Soluble tachyzoite antigen (STAg) or cps1-1 tachyzoites were added and 
cells were incubated at 37ºC in humidified 5% CO2 for 48 and 72 hrs, then 
supernatants were recovered for ELISA.  
 
ELISA  
Cytokine ELISA for IFN-γ and IL-12/23p40 were carried out as previously described 
(61).  
 
Statistical analyses  
Student’s t test was employed to analyze statistical differences between groups. P 
values < 0.05 were considered significant. Survival curves were analyzed using a 
logrank test. All experiments were repeated a minimum of 2-3 times.  
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Results 
MyD88 is required to survive oral infection with T. gondii 
It was previously shown that genetic inactivation of Toll/IL-1R adaptor molecule 
MyD88 rendered mice highly susceptible to i. p. infection with Toxoplasma (14, 15). 
We sought to determine if lack of MyD88 also resulted in susceptibility during 
infection initiated by the natural route of infection, namely, through oral inoculation. 
As shown in Fig. 4.1A, MyD88-/- mice, but not MyD88+/+ littermates, uniformly 
succumbed to infection after oral administration of low virulence ME49 cysts. 
Interestingly, in parallel groups of mice i. p. infected with the same cyst number, 
MyD88-/- mice succumbed at a slightly, but significantly (p = 0.0015), accelerated rate 
(Fig. 4.1B). In H & E staining of gut and Peyer’s patches we failed to detect major 
differences in pathology of WT and KO mice, but in livers we found MyD88-
dependent inflammatory infiltrates (Fig. 4.2).  
 
Death during i. p. infection of MyD88-/- animals is associated with uncontrolled 
tachyzoite replication and dissemination (14, 15). Likewise, we found greater numbers 
of parasites during low dose oral infection of MyD88-/- relative to MyD88+/+ 
littermates. In WT mice, low numbers of tachyzoites were present in lamina propria 
(Fig. 4.3A) and Peyer’s patches (Fig. 4.3C) of the small intestine. In contrast, high 
parasite numbers were present at these locations in KO animals (Fig. 4.3B and D, 
respectively). Regions of lymphocyte depletion were also apparent in Peyer’s patches 
of KO mice (Fig. 4.3D) and these areas were markedly less extensive in WT animals 
(Fig. 4.3C). These differences were even more striking during high dose ME49 
infection, where uncontrolled parasite replication was apparent in Peyer’s patches of 
MyD88-/- but not MyD88+/+ littermates (Fig. 4.4).  
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Figure 4.1. MyD88 is required to survive oral infection with Toxoplasma gondii. 
Groups of MyD88-/- and MyD88+/+ littermates (5 per strain) were orally and i. p. 
infected at the same time with 20 cysts of the ME49 strain. Panel A, oral infection; 
panel B, i. p. infection. Closed symbols, MyD88+/+ mice; open symbols, MyD88-/- 
mice.  
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Figure 4.2. Pathology of MyD88-/- and MyD88+/+ mice during oral infection. Mice 
(2 per group) were orally infected with 20 ME49 cysts, then at Day 7 post-inoculation 
the indicated tissues and organs were harvested for staining by H & E.  In both strains, 
histopathological changes were present in gastrointestinal tracts, particularly in the 
Peyer’s patches, and livers. The bar in D denotes 200 µm. 
 
MyD88-/- 
Small 
intestine 
Peyer’s  
patch 
Liver 
MyD88+/+ 
 114 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Parasite number in gut mucosal tissue during oral infection is 
increased in the absence of MyD88. Wild-type (A and C) and knockout (B and D) 
mice were infected with 20 ME49 cysts and gut tissues were collected 7 days later. 
Samples were subjected to immunohistochemical staining using an anti-Toxoplasma 
antiserum. A and B, villi and underlying lamina propria. B and D, Peyer’s patches. 
The bar in D denotes 100 µm. 
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Figure 4.4. Increased parasite numbers in Peyer’s patches in MyD88-/- mice 
during high dose oral infection.  Wild-type (A and C) and MyD88 knockout (B and 
D) mice were orally infected with 100 ME49 cysts. Ten days later, small intestines 
were isolated and subjected to immunohistochemical staining with an anti-Toxoplasma 
antiserum. The regions delineated by rectangles in A and B were imaged at high 
magnification in C and D. In A and B, the bar denotes 250 µm; in C and D the bar 
denotes 50 µm. 
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Early but not late neutrophil recruitment is dependent upon MyD88 
We next examined mesenteric lymph node and spleen cell populations of WT and KO 
mice undergoing oral T. gondii infection. In mesenteric lymph nodes of Day 4-
infected animals, there was a striking decrease in Gr-1+ neutrophil recruitment in KO 
relative to WT animals, but populations of macrophages (MØ), DC, as well as B and T 
lymphocytes were normal (Fig. 4.5A). Nevertheless, neutrophil numbers in mesenteric 
lymph nodes recovered in MyD88-/- mice by day 7 post-infection (Fig. 4.5B). 
Similarly, neutrophil numbers in spleens of Day 4-infected KO animals were less than 
in WT littermates (Fig. 4.5C), but this difference was minimal at day 7 post-infection 
(Fig. 4.5D). We next stained sections of small intestine with antibody to 
myeloperoxidase (MPO), an enzyme that is expressed at high level in PMN. We found 
an influx of MPO+ cells into the lamina propria of WT (Fig. 4.5E) but not MyD88 KO 
(Fig. 4.5F) animals at day 4 post-infection. In day 7-infected mice, lamina propria 
neutrophils were recruited in greater number in WT mice relative to day 4 (Fig. 4.5G), 
and this response did not require functional MyD88 (Fig. 4.5H). We, and others, 
previously reported rapid recruitment of Gr-1+ neutrophils into the peritoneal cavity 
early during i. p. infection with high virulence RH strain tachyzoites (36, 37). In Fig. 
4.5I we show that neutrophil recruitment in this model is also highly MyD88-
dependent.   
 
IL-12/23p40 production is MyD88-dependent, whereas IFN-γ production is 
delayed but reaches normal levels in the absence of MyD88  
During in vitro parasite antigen stimulation of splenocytes (Fig. 4.6A-C) and 
mesenteric lymph node cells (Fig. 4.6D-F), production of IL-12/23p40 was highly 
MyD88-dependent using as a cell source noninfected (A and D), Day 4 (B and E) and 
Day 7 (C and F) orally infected mice. Nevertheless, in splenocytes at all time points 
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Figure 4.5. Neutrophil recruitment depends upon MyD88 during early infection. 
Mesenteric lymph node (A and B) and spleen (C and D) cells were prepared from 
MyD88-/- and MyD88+/+ littermates on Day 4 (A and C) and Day 7 (B and D) post oral 
infection with ME49 (20 cysts). Cells were subjected to flow cytometric analysis and 
total cell numbers were subsequently calculated (2 mice per group). Closed bars, 
MyD88+/+; open bars, MyD88-/-. PMN, Gr-1+F480- cells; MØ, Gr-1-F480+ cells; DC, 
CD11c+ cells; B, B220+ cells. *, p <0.05. In panels E-F, small intestines were 
collected from MyD88+/+ (E and G) and MyD88-/- (F and H) mice at Days 4 (E and F) 
and 7 (G and H) after oral ME49 infection. Sections were subsequently subjected to 
immunohistochemical staining with an anti-myeloperoxidase (MPO) antiserum. 
Arrows in panel E point to areas of infiltrating MPO+ cells. Bar denotes 100 µm. In I, 
wild-type and knockout mice (n = 2 per strain) were infected by i. p. injection of 106 
RH strain tachyzoites. Peritoneal cells were collected 6 hr later for flow cytometric 
analysis.    
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Figure 4.6. Production of IL-12/23p40 during infection is highly MyD88 
dependent. Spleen (A-C) and mesenteric lymph nodes (D-F) were collected from 
noninfected, Day 4 and Day 7 orally infected mice (20 ME49 cysts). Single cell 
suspensions were prepared and cells were cultured with the indicated amounts of 
soluble tachyzoite lysate antigen (STAg). Closed bar, cells from wild-type mice; open 
bar, cells from knockout animals.    
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low but detectable levels of MyD88-independent p40 could be detected, and at day 7 
post-infection residual IL-12 was apparent in mesenteric lymph node cultures from  
MyD88-/- animals. 
 
Next, we measured production of IFN-γ, a cytokine long recognized as the major 
mediator of resistance to T. gondii (38). As shown in Fig. 4.7, antigen-induced IFN-γ 
release by splenocytes (A) and mesenteric lymph node cells (B) was strictly dependent 
upon MyD88 at Day 4 post-infection. This result was confirmed and extended by 
intracellular cytokine staining of soluble tachyzoite lysate (STAg)-stimulated cells 
(Fig. 4.7C). Thus, in the spleen (SPL), a small proportion CD4+ T cells produced IFN-
γ in dependence upon MyD88 (0.4 vs. 0.03% for WT and KO, respectively). 
Interestingly, there was a strong MyD88-dependent IFN-γ response by splenic CD8+ T 
cells under the same conditions (10.0 vs. 0.57% for WT and KO, respectively). 
However, in mesenteric lymph node (MLN) cultures, the STAg-induced IFN-γ 
response was relatively minor, and most of the MyD88-dependent IFN-γ derived from 
CD4+ T lymphocytes. It is of further interest to note evidence for a default to the Th2 
pathway in MyD88-/- mesenteric lymph node CD4+ T cells (0.09 vs. 0.56% IL-4-
positive in WT and KO, respectively) that was not apparent in splenic cultures (Fig. 
4.7C). Thus, as previously reported in an i. p. model of Toxoplasma soluble antigen 
injection (39), there is an increase in the Th2 response in the absence of MyD88, but 
here we show this response is weak and is restricted to mesenteric lymph nodes during 
oral infection.  
 
When we examined IFN-γ responses at day 7 post-oral infection, strikingly different 
results were obtained compared to the Day 4 response. Thus, at Day 7, splenocytes 
(Fig. 4.8A) and mesenteric lymph node cells (Fig. 4.8B) released high levels of IFN-γ 
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Figure 4.7. Early acute production of IFN-γ during oral Toxoplasma infection 
requires MyD88. Spleen cells (A) and mesenteric lymph node cells (B) from mice 
orally infected 4 days previously with 20 ME49 cysts were cultured with the indicated 
amounts of tachyzoite lysate antigen. Closed bar, MyD88+/+ cells; open bar, MyD88-/- 
cells. (C) Spleen and mesenteric lymph node cells from Day 4 orally infected animals 
were subjected to CD4 and CD8 surface staining and intracellular IFN-γ and IL-4 
staining 72 hr after STAg restimulation (25 µg/ml). Cytokine expression was 
evaluated after gating on CD4+ and CD8+ T cells. The results show one representative 
mouse out of a total of three from each strain.     
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Figure 4.8. Delayed IFN-γ production and emergence of Th1 T cells does not 
require MyD88. Spleen (A) and mesenteric lymph node (B) cells from Day 7 orally 
infected wild-type (closed bars) and knockout (open bars) mice were cultured with the 
indicated amounts of parasite lysate antigen. (C) MyD88+/+ and MyD88-/- cells from 
spleen and mesenteric lymph nodes of Day 7 orally infected mice were cultured for 6 
hr without further antigen stimulation in the presence of Brefeldin A. The cells were 
subsequently stained for CD4 and intracellular IFN-γ and IL-4. The results show one 
representative mouse out of a total of three from each strain. 
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independently of MyD88 and without the need for further in vitro antigen stimulation. 
In the presence of parasite antigen, these responses were only modestly increased. In 
Fig. 4.8C, we determined the source of IFN-γ by ex vivo staining splenocytes and 
mesenteric lymph node cells without further antigen stimulation. In this case, there 
was a vigorous MyD88-independent splenic CD4+ T cell response (Fig. 4.8C; 6.56 and 
6.87% for WT and KO, respectively). In mesenteric lymph nodes, there was also a 
strong CD4+ T lymphocyte IFN-γ response, although this was partially MyD88 
dependent (7.49 vs. 3.07% for WT and KO, respectively). In both spleen and 
mesenteric lymph nodes, the IFN-γ response by CD8+ T cells was extremely weak 
(data not shown).  
 
MyD88-/- mice display a defect in Irgm3 (IGTP) expression in gut mucosa at Day 
4 but not Day 7 post infection   
Previously it was found that IFN-γ-dependent expression of p47 GTPase family 
member Irgm3/IGTP is necessary to survive Toxoplasma infection (40). Here, we 
determined the expression pattern of this molecule in small intestines of orally 
inoculated MyD88-/- and MyD88+/+ mice. Interestingly, at day 4 post-infection we 
detected expression of Irgm3 in endothelial cells in basement membrane-submucosal 
regions of WT mice (Fig. 4.9A and C) and this response was absent in mice lacking 
MyD88 (Fig. 4.9B and D). However, at day 7 after infection, small intestine epithelial 
cells of WT mice were strongly positive for Irgm3, and this response was identical in 
tissues from MyD88 KO animals (Fig. 4.9). In sum, during early (day 4) oral 
infection, IL-12/23p40 and T cell IFN-γ expression was dependent upon MyD88. 
Similarly, neutrophil recruitment and Irgm3 expression, two responses previously 
implicated in resistance to Toxoplasma (40, 41), also relied on functional MyD88. 
Nevertheless, with the exception of IL-12/23p40 expression, each of these immune 
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Figure 4.9. Early endothelial cell expression of Irgm3/IGTP is dependent upon 
MyD88. MyD88+/+ (Panels A, C and E) and MyD88-/- (panels B, D and F) were orally 
infected and small intestine tissue was collected 4 (panels A-D) and 7 (panels E and F) 
days later. Endothelial cells in WT (arrows in panels A and C) but not KO (arrows, 
panels B and D) stained positive for Irgm3/IGTP. At day 7 post-infection, epithelial 
cells of both WT (panel E) and KO (panel F) were Irgm3/IGTP positive. The results 
show one representative mouse out of a total of three from each strain. In panels A, B, 
E and F the bar denotes 20 µm. In panels C and D the bar indicates 40 µm.       
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responses reached normal levels without the need for MyD88 by day 7 after infection. 
 
MyD88 is not required for protective immunity to Toxoplasma     
Although the delayed T cell IFN-γ response did not require MyD88 during oral 
infection (Fig. 4.8), and although CD4+ and CD8+ T lymphocyte expression of 
activation marker CD69 was identical in the presence and absence of MyD88 (Fig. 
4.10), KO mice were unable to control infection and the animals succumbed to 
Toxoplasma (Fig. 4.1). This precluded us from rigorously testing whether MyD88-/- 
mice developed a protective immune response to challenge infection, which is known 
to depend upon T cell production of IFN-γ in normal mice (30). To circumvent this 
limitation, we employed Toxoplasma mutant cps1-1. This RH-derived parasite strain 
is a uracil auxotroph that invades but does not replicate in host cells. Infection of mice 
with cps1-1 results in nonpersistent infection that fails to cause pathology associated 
with wild type T. gondii infection (42). Importantly, cps1-1 vaccination has been 
shown to induce protective immunity to challenge infection (42, 43). As shown in Fig. 
4.11A (graph a), both MyD88+/+ and MyD88-/- mice vaccinated with cps1-1 developed 
protective immunity to challenge with RH strain parasites. In contrast, nonvaccinated 
mice succumbed within two weeks of infection with this highly virulent parasite 
strain. We also vaccinated IL-12/23 p40-/- mice with cps1-1 (graph b). In this case, the 
animals failed to develop a protective immunity to RH challenge.  
 
We examined naïve (CD62LhiCD44lo), Effector/Effector Memory (CD62LloCD44hi), 
and Central Memory (CD62LhiCD44hi) splenic T cell populations after cps1-1 
vaccination of MyD88+/+ and MyD88-/- animals. As shown in Fig. 4.11B, there were 
no major differences between WT and KO populations amongst CD4+ (a and b) or 
CD8+ (c and d) T cell populations. To distinguish between Effector and Effector  
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Figure 4.10. Normal expression of CD69 in the absence of MyD88 during T. 
gondii infection. A-B, expression of CD69 on CD4+ T cells in the spleen and 
mesenteric lymph node, respectively, was examined in noninfected, Day 4, and Day 7 
orally infected MyD88+/+ (closed bars) and MyD88-/- (open bars) mice. C-D, 
expression of CD69 on CD8+ T cells in the spleen and mesenteric lymph node, 
respectively. Two animals were used at each time point.    
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Figure 4.11. Adaptive immunity to T. gondii is functional in the absence of 
MyD88. In panel A, mice were vaccinated by i. p. injection of Toxoplasma uracil 
auxotroph cps1-1 then challenged two weeks later by subcutaneous injection of RH 
strain tachyzoites. In graph a, MyD88 WT and MyD88 KO animals were used. In 
graph b, IL-12p40 WT and IL-12p40 KO mice were subjected to vaccination and 
challenge. Panel B, two weeks following cps1-1 vaccination, splenic CD4+ (a and b) 
and CD8+ (c and d) T lymphocytes from WT (a and c) and MyD88 KO (b and d) 
animals were assessed for expression of CD62L and CD44 to identify populations of 
naïve (CD62LhiCD44lo), Effector/Effector Memory (CD62LloCD44hi), and Central 
Memory (CD62LhiCD44hi) cells. In panel C, two weeks after vaccination with cps1-1, 
splenocytes MyD88+/+ and MyD88-/- mice were subjected to in vitro stimulation with 
the indicated multiplicity of infection (MOI) of cps1-1. Supernatants were assessed 
populations that both possess a CD62LloCD44hi surface phenotype, we assessed CCR7 
from production of IL-12/23p40 (graph a) and IFN-γ (graph b). 
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Memory populations that both possess a CD62LloCD44hi surface phenotype, we 
assessed CCR7 that is expressed at high level on Effector but not Effector Memory 
subpopulations. Here again, we found no difference on these populations amongst WT 
and KO T cells  (Fig. 4.12).   
 
In splenocyte cultures from cps1-1 vaccinated mice, production of IL-12/23p40 was 
barely detectable in cells from MyD88 KO compared to the response of WT cells (Fig. 
4.11C, graph a). In contrast, the IFN-γ recall response of MyD88-/- cells was 
indistinguishable from that of cells from WT littermates (Fig. 4.11C, graph b). We 
further probed the source of IFN-γ employing intracellular cytokine staining. Both 
CD4+ and CD8+ T cells from KO and WT mice contributed to IFN-γ production 
during in vitro recall with cps1-1 parasites (Fig. 4.13). Thus, cps1-1 vaccination of 
MyD88-/- mice results in protective adaptive immunity that, by the parameters 
measured, appears identical to that induced in MyD88+/+ animals. 
 
Discussion 
TLR-MyD88 signaling is required for resistance to several protozoan pathogens, and 
parasite ligands that possess TLR activating capability are increasingly being 
identified (10). For the case of Toxoplasma, parasite profilin and tachyzoite surface 
GPI anchors are recognized by TLR11 and TLR2/4 respectively (18, 32, 33). In vitro 
studies using models of i. p. infection or i. v. tachyzoite injection have shown that 
MyD88 is required to control infection, and that the immune response to the parasite 
deviates from a Th1 to a Th2 response in the absence of this TLR adaptor (14, 39).  
 
Here, we examined how lack of MyD88 signaling impacts host defense in animals 
undergoing oral infection with T. gondii. As during i. p. infection, orally infected  
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Figure 4.12. Normal distribution of CCR7 on Effector/Effector Memory T cell 
populations in cps1-1 vaccinated MyD88-/- mice. Splenocyte populations from mice 
vaccinated with cps1-1 were subjected to flow cytometric analysis with antibodies 
specific for CD4, CD8, CD44, CD62L and CCR7. CD4+ and CD8+ Effector/Effector 
Memory (CD44hiCD62Llo) were assessed for CCR7 expression to distinguish Effector 
(CCR7+) from Effector Memory (CCR7-) subpopulations.      
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Figure 4.13. Vaccination with cps1-1 generates splenic CD4+ and CD8+ T cells 
that contribute to IFN-γ production in MyD88+/+ and MyD88-/- mice. Splenocytes 
from cps1-1-vaccinated WT and KO animals (3 per group) were cultured for 48 hr in 
medium alone or with cps1-1 at a ratio of 0.5 parasites per cell. Brefeldin A was added 
during the last 4 hr of culture. Cells were subsequently recovered for intracellular IFN-
γ staining and surface staining for CD4 and CD8.    
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MyD88-/- mice displayed early death associated with uncontrolled parasite replication. 
Like other studies employing the i. p. infection model, the IL-12 response was 
severely curtailed during oral infection of MyD88 KO mice. Early during oral 
infection of MyD88-/- animals, we found that neutrophil recruitment to mucosal tissues 
was defective, as was production of T cell IFN-γ and induction of Irgm3/IGTP, an 
IFN-γ-inducible p47 GTPase required to survive acute T. gondii infection (40). 
Importantly, later during acute infection MyD88-independent Th1 responses emerged. 
The appearence of an apparently intact Th1 response in the absence of MyD88 
prompted us to examine whether we could elicit protective immunity in the absence of 
this signaling adaptor. Accordingly, we vaccinated mice with the avirulent cps1-1 
Toxoplasma strain. This treatment stimulated protective immunity and strong IFN-γ 
production independently of MyD88. Taken together, our data suggest MyD88 
signaling exerts anti-Toxoplasma activity at a critical early time in infection, but that it 
is not required to induce strong Th1-based immunity to this parasitic pathogen.   
 
Our results were unexpected because it has been reported that MyD88 signaling plays 
a role in shaping adaptive immunity to T. gondii. For example, during i. p. 
Toxoplasma infection, defective T cell IFN-γ production was observed during acute 
infection (14). Following i. v. injection of soluble tachyzoite lysate antigen, the 
immune response in MyD88-/- animals deviates from a Th1 to Th2 cytokine response 
following i. v. injection of soluble tachyzoite lysate antigen (39). In addition, i. v. 
injection of parasite profilin has been shown to trigger a TLR11/MyD88-dependent 
Th1 response to the profilin molecule itself (35). Recently, it was found that MyD88 
expression in T cells was required for IFN-γ production and survival during i. p. T. 
gondii infection (44). We do not completely understand why MyD88-/- animals 
undergoing oral T. gondii infection develop strong, albeit delayed, Th1 responses, 
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when other routes of infection and antigen delivery elicit MyD88-dependent Th1 
responses. It seems possible that animals succumb with insufficient time to generate a 
Th1 response during i. p. infection. Another possibility is that DC populations in 
mucosal tissues, or possibly signals elicited by gut flora in combination with 
Toxoplasma, play a role in triggering MyD88-independent Th1 immunity during oral 
infection (45, 46). For the case of protective immunity induced by cps1-1 vaccination, 
it is might be that multiple exposure to low doses of nonvirulent tachyzoites induces 
MyD88-independent adaptive immunity that is not elicited by i. p. infection with a 
single dose of parasites.  
 
Our results suggest that the major role for MyD88 during oral Toxoplasma infection is 
in anti-microbial effector activity. This is in line with several other groups. For 
example, T cell-dependent antibody responses induced by a panel of adjuvants 
proceeded normally in the absence of MyD88 and TRIF signaling (47). Similarly, 
MyD88-deficient mice mount normal protective antibody responses and inflammatory 
arthritis during Borrelia burgdorferi infection (27). During infection with the fungal 
pathogen Aspergillus fumigatus Th1 responses in infected airways do not require 
MyD88, although T-bet induction was enhanced by MyD88 signaling in the draining 
lymph nodes (48). It was also found that Listeria infection induces a protective CD8+ 
T cell response in the absence of MyD88 signaling (25, 26). During aerosol infections 
with Mycobacterium tuberculosis, there is evidence both for and against a role for 
MyD88 in adaptive immunity, depending on the study (9, 49-52). Regardless, in most 
of these cases, and as during oral Toxoplasma infection, while acquired immunity 
could proceed without MyD88, this adaptor molecule was clearly required for 
pathogen control during innate immunity. 
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At present we do not know why MyD88-/- mice are unable to control T. gondii 
infection. Recruitment of neutrophils to mucosal tissues was defective in the knockout 
mice during early stages of infection, and this possibly underlies the susceptibility of 
these animals. Others have also found that neutrophil recruitment during infection 
relies upon MyD88-dependent signaling (53, 54). Previously, we reported that 
depletion of neutrophils with an anti-Gr-1 antibody resulted in susceptibility to oral T. 
gondii infection (41). Therefore, it is possible that defective neutrophil recruitment 
during early infection allows increased parasite survival in the intestine, ultimately 
leading to death of the animals. Nevertheless, we interpret results obtained using anti-
Gr-1 mAb with caution, since the Gr-1 epitope is also expressed by other types of 
myeloid cells (55).    
 
Our data for the first time show tissue localization of IFN-γ-inducible Irgm3/IGTP, a 
molecule required to survive acute Toxoplasma infection (40). Interestingly, 
Irgm3/IGTP was expressed in endothelial cells of the intestinal submucosa in an 
MyD88-dependent manner during early infection. Later, this p47 GTPase was highly 
expressed in epithelial cells of the small intestine in both MyD88+/+ and MyD88-/- 
mice. It is difficult to understand how early MyD88-dependent Irgm3/IGTP 
expression confined to endothelial cells could contribute to resistance to T. gondii 
infection, which is uniformly spread throughout mucosal tissues. Although the 
function of Irgm3/IGTP and other p47 GTPases is not well understood, these 
molecules have been implicated in autophagic destruction of the parasitophorous 
vacuole in tachyzoite-infected macrophages and astrocytes (56, 57). However, we 
have so far not detected differences in IFN-γ-mediated macrophage killing of 
tachyzoites in the presence and absence of MyD88 (Fig. 4.14).   
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Figure 4.14. IFN-γ-activated macrophages efficiently control infection in the 
absence of MyD88. Bone marrow-derived macrophages were subjected to 18 hr 
activation with IFN-γ or incubation in medium alone. Cells were subsequently infected 
with PTG strain tachyzoites, and infection levels were determined 12 hr later by flow 
cytometry, assessing levels of the tachyzoite surface p30 antigen in F4/80-positive 
macrophages. 
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Strong MyD88-independent T cell IFN-γ responses were elicited during both oral 
ME49 infection and cps1-1 vaccination. Inasmuch as production of IL-12 in both 
cases was minimal, this raises the question of how T cell IFN-γ responses are 
generated in these cases. Two related possibilities are that residual MyD88-
independent IL-12 is sufficient to drive Th1 differentiation, or that more robust 
MyD88-independent IL-12 responses occur at sites other than the draining lymph 
nodes and spleen that were examined in this study. It is also possible that Th1 
responses are triggered independently of IL-12 in the absence of MyD88. However, at 
least for the case of cps1-1-induced immunity, absence of IL-12/23p40 resulted in lack 
of a protective response, a result that argues for IL-12 as a mediator of protection in 
cps1-1 vaccinated MyD88-/- animals. In this regard, we have found that bone marrow-
derived macrophages infected with the RH Toxoplasma strain produce IL-12 
independently of signaling through MyD88 (58), yet the same parasite strain clearly 
triggers MyD88-dependent IL-12 in splenic DC (our unpublished results and refs. 14, 
18). Further work will be required to determine host mediators involved in generating 
MyD88-independent Th1 responses during Toxoplasma infection.     
 
In sum, our results argue that MyD88-dependent signaling is crucial in anti-microbial 
effector function against T. gondii. Nevertheless, the view that this adaptor molecule 
plays an essential role in bridging innate and adaptive immunity to Toxoplasma may 
require revision. Other signaling molecules and recognition systems are also likely to 
be important determinants of adaptive immunity to this parasite. Identifying such 
molecules will provide important insight into immune recognition of Toxoplasma and 
other microbial pathogens. 
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1. Summary of findings 
Toxoplasma gondii infection elicits strong Th1 immunity. IL-12-dependent IFN-γ 
production is essential for resistance to T. gondii infection (1-3). Increased host 
susceptibility to microbial infection in Gr-1+-depleted mice suggests a role for this 
granulocyte population in providing resistance during Toxoplasma and other microbial 
infections (4-6). The neutrophil is a source of IL-12, and it may be released from pre-
formed stores or synthesized de novo (7). The JNK signaling pathway has been 
implicated in IL-12 production from macrophages and dendritic cells (8). In Chapter 2 
I found that JNK2 is the major isoform expressed in mouse neutrophils. Importantly,  
JNK2 plays a major role in PMN IL-12 and CCL2/MCP-1 production in response to 
Toxoplasma infection. In contrast, JNK2 is not required for oxidative burst and 
phagocytic activity in mouse PMN, although I found a partial role for the MAPK in 
chemotaxis. 
 
In Chapter 3 I examined the in vivo response to Toxoplasma in the absence of JNK2. I 
hypothesized that JNK2-deficient mice would be more susceptible to T. gondii 
infection as a result of reduced IL-12 production by PMN. Surprisingly, JNK2 
deletion confered resistance to Toxoplasma, and this was associated with lower 
parasite burden in the brain and intestinal tissues. Also, I found that immune-mediated 
gut pathology was alleviated in the absence of this MAPK along with decreased PMN 
number in intestinal tissues. In contrast to in vitro data, IL-12 production from 
splenocytes and splenic DCs cultured with parasite molecules was slightly higher in 
the absence of JNK2. IFN-γ was also found slightly increased in splenocytes cultured 
with parasite antigens. Thus, this evidence leads me to believe that JNK2 expression 
contributes to enhanced susceptibility during Toxoplasma infection. 
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Since JNK2 does not seem to be required for IL-12 induction during T. gondii 
infection in vivo, I was interested in finding other signaling molecules that were 
needed for IL-12 production and resistance to in vivo infection with this parasite. 
MyD88 is a key component of the TLR signaling pathway that is responsible for IL-12 
synthesis in response to intraperitoneal Toxoplasma infection (9). In Chapter 4,  we 
examined the role of this adaptor molecule in the context of oral infection, the natural 
mode of transmission. In common with i. p. infection (9), MyD88 was also required 
for resistance to T. gondii introduced by oral infection. Decreased PMN recruitment 
was observed in the absence of MyD88. While IL-12 responses were highly dependent 
upon this adaptor molecule, splenic CD4+ and CD8+ IFN-γ responses reached normal 
levels in the absence of MyD88. Furthermore, MyD88-/- mice vaccinated with an 
attenuated parasite strain developed protective immunity to lethal challenge infection, 
and this was associated with a strong Th1 response. Thus, while MyD88 is required 
for controlling T. gondii replication it is not needed for development of protective 
immunity against Toxoplasma infection. 
 
2. Role of JNK2 in response to T. gondii infection in vitro and in vivo 
The JNK signaling pathway has been widely implicated in diverse physiological 
processes including embryonic development, cell survival, apoptosis, proliferation, 
and inflammatory responses (10). In the immune response, there is evidence that JNK 
signaling is required for polarized Th1 differentiation and effector cytokine production 
(11). However, the role of JNK appears to be dependent on the context of cell type and 
biological function. As previously reported from our lab and in contrast to PMN, 
JNK2 is not required for Toxoplasma-induced IL-12 production in bone-marrow 
derived macrophages. However, a pharmacological JNK specific inhibitor, SP600125, 
inhibits parasite-triggered IL-12 release in macrophages (12). This suggests that other 
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JNK, most probably JNK1, plays a role in T. gondii-induced IL-12 induction. As 
shown in Chapter 2 and 3, the defect of PMN IL-12 production in the absence of 
JNK2 in vitro does not reflect the overall in vivo IL-12 response during infection of 
JNK2 KO mice. In this case, I found evidence that JNK2 negatively regulates IL-12 
production during Toxoplasma infection, although the effects were marginal. 
Nevertheless, my findings are in common with others in human monocytes, in which 
JNK downregulates Gi-protein-mediated IL-12 production (13).   
 
Studies in humans suggest that neutrophil JNK functions differently compared to 
responses in mouse neutrophils. For example, JNK in human PMN remains 
unphosphorylated after PMN incubation with several activation stimuli. Also, 
inhibition of JNK with SP600125 does not inhibit inflammatory cytokine gene 
expression in human PMN suggesting that this MAPK is not important for induction 
of inflammatory mediators (15). However, another study demonstrated that human 
PMNs triggered with LPS express CCL2 through JNK activation, correlating with my 
findings (16). 
 
The role of JNK in adaptive immunity has been studied in several infectious disease 
models. During influenza and lymphocytic choriomeningitis virus infection, JNK2 
negatively regulates expansion and effector function of CD8+ T cells (17, 18). Since  
resistance to Toxoplasma infection requires a CD8+ IFN-γ response (19, 20), this 
might explain why JNK2-/- mice are more resistant during T. gondii infection. In 
common with our result, disruption of JNK2 confers enhanced survival in response to 
Plasmodium berghei ANKA infection. However, unlike my results this was associated 
with lower systemic TNF-α production (21). In addition, JNK-mediated negative 
regulation of IFN-γ production was demonstrated during Anaplasma phagocytophilum 
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infection (22). Together, my results and those of others suggest that the predominant 
role of JNK2 during microbial infection in vivo is to downregulate proinflammatory 
responses. 
 
In addition to a role in inflammatory responses, JNK is implicated in cell migration in 
innate immune cells, including neutrophils. I also found that JNK2 plays a role in 
PMN chemotaxis in response to the IL-8-related chemokine, KC. In line with the in 
vitro data, I found decreased PMN recruitment in vivo in the absence of JNK2 during 
early T. gondii infection. Studies by other groups support the role of JNK in 
chemotaxis and recruitment during infection and inflammation. For example, the JNK 
signaling pathway is required for TNF-α-mediated E-selectin expression in 
endothelial cells which is essential for PMN extravasation to the site of infection (23). 
JNK also mediates platelet factor 4-induced neutrophil adhesion to endothelial cells 
(24). Furthermore, inhibition of the JNK pathway disrupts PMN actin assembly after 
LPS stimulation in the lung, leading to reduce pulmonary neutrophil accumulation 
(25). JNK is also activated during CCR7 ligand-induced DC migration (26). 
Collectively, these studies suggest an important function for JNK in cell migration. 
 
3. Role of MyD88 in IL-12 induction during T. gondii oral infection 
TLR adaptor molecule MyD88 has been implicated in innate recognition and 
resistance to several protozoan pathogens including Toxoplasma, Plasmodium berghei, 
Leishmania major and Trypanosoma cruzi (27). Several protozoan TLR ligands have 
now been identified. During Toxoplasma infection, parasite profilin and 
glycosylphosphatidylinositol (GPI) protein anchors have emerged as ligands for 
TLR11 and TLR2/4, respectively (28-30). 
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Although MyD88 is often proposed as being required for adaptive immunity, we 
clearly show this is not the case for T. gondii infection. These findings are supported 
by studies with other microbial pathogens including Aspergillus fumigatus (31), 
Borrelia burgdorferi (32), and Listeria monocytogenes (33). It is possible that residual 
MyD88-dependent IL-12 during infection with Toxoplasma and other microbial 
pathogens is sufficient to drive the adaptive immune response. 
 
We revealed a requirement for MyD88 signaling in PMN recruitment during early T. 
gondii infection. The defect in PMN recruitment in the absence of MyD88 is in line 
with other infectious disease models including Chlamydia pneumoniae and 
Citrobacter rodentium (36, 37). Also, the IL-1R-MyD88 signaling pathway has been 
shown to be involved in neutrophil recruitment in sterile inflammatory responses (38). 
Whether Toxoplasma-triggered MyD88-dependent neutrophil recruitment is a 
consequence of TLR or IL-1R signaling is not yet known. 
 
4. Future directions and unanswered questions 
Several questions are raised by my findings. Despite the fact that JNK2 is required for 
T. gondii induced-IL-12 production in mouse neutrophils in vitro, the studies on JNK2 
function in mice have failed to demonstrate a corresponding role in the response to 
Toxoplasma infection. Instead, my data suggests that JNK2 is a negative regulator for 
IL-12 production in vivo, and T. gondii-induced intestinal pathology in JNK2-/- mice is 
alleviated. Nevertheless I did not observe a consistent JNK2 requirement for in vivo 
TNF-α and nitric oxide, the key players for T. gondii-mediated-immunopathology. 
Further analysis of cytokine and chemokine expressed by intraepithelial lymphocytes 
and cellular infiltrates isolated from infected ileum might provide explanation of why 
JNK2-/- mice are more resistant to Toxoplasma infection. In addition, CD8+ T cell 
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activity in JNK2-/- mice might be enhanced and contribute to disease resistance during 
T. gondii infection, a possibility that could be addressed in future studies. 
 
Since I found decreased PMN recruitment to the small intestines was associated with 
relieved pathology in the absence of JNK2, it is tempting to speculate that PMN might 
play a role in damage to the intestinal mucosa. Because I found Toxoplasma triggered 
JNK2-dependent CCL2/MCP-1 production in PMN in vitro, it might be possible that 
JNK2 might be required for CCL2 induction in vivo during Toxoplasma infection. 
This could contibute to enhanced recruitment of other cells responsible for immune-
mediated gut pathology. In this regard, it is of interest that our lab has found that 
genetic deletion of CCR2, the receptor for CCL2, also results in resistance to 
Toxoplasma-induced ileitis during oral infection (Egan and Denkers, manuscript in 
preparation). 
 
Resistance to Toxoplasma infection requires IFN-γ production, a response that is 
widely viewed as being dependent upon IL-12. Yet, despite minimal levels of IL-12, a 
strong protective Th1 response emerged in the absence of MyD88. It is possible that 
only residual amounts of IL-12 are required for Th1 induction, a possibility that could 
be addressed by in vivo depletion with blocking antibody. It is also possible that there 
are major sources of MyD88-independent IL-12 that escaped detection on our studies. 
For example, the activity of lamina propria DC, a major subset of professional antigen 
presenting cells, was not determined in these studies. Regardless, a question remaining 
is what drives IL-12 in the absence of MyD88. Possibly TLR3 signaling (which unlike 
other TLR does not involve MyD88) is required. It is also possible that other 
intracellular sensors of infections, such as Nod1 and Nod2, are involved. Future work 
will be required to address these important issues. 
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